<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">32998479</PMID><DateCompleted><Year>2021</Year><Month>02</Month><Day>25</Day></DateCompleted><DateRevised><Year>2021</Year><Month>02</Month><Day>25</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1422-0067</ISSN><JournalIssue CitedMedium="Internet"><Volume>21</Volume><Issue>19</Issue><PubDate><Year>2020</Year><Month>Sep</Month><Day>28</Day></PubDate></JournalIssue><Title>International journal of molecular sciences</Title><ISOAbbreviation>Int J Mol Sci</ISOAbbreviation></Journal><ArticleTitle>Melatonin and Autophagy in Aging-Related Neurodegenerative Diseases.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">7174</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/ijms21197174</ELocationID><Abstract><AbstractText>With aging, the nervous system gradually undergoes degeneration. Increased oxidative stress, endoplasmic reticulum stress, mitochondrial dysfunction, and cell death are considered to be common pathophysiological mechanisms of various neurodegenerative diseases (NDDs) such as Alzheimer's disease (AD), Parkinson's disease (PD), Huntington's disease (HD), organophosphate-induced delayed neuropathy (OPIDN), and amyotrophic lateral sclerosis (ALS). Autophagy is a cellular basic metabolic process that degrades the aggregated or misfolded proteins and abnormal organelles in cells. The abnormal regulation of neuronal autophagy is accompanied by the accumulation and deposition of irregular proteins, leading to changes in neuron homeostasis and neurodegeneration. Autophagy exhibits both a protective mechanism and a damage pathway related to programmed cell death. Because of its "double-edged sword", autophagy plays an important role in neurological damage and NDDs including AD, PD, HD, OPIDN, and ALS. Melatonin is a neuroendocrine hormone mainly synthesized in the pineal gland and exhibits a wide range of biological functions, such as sleep control, regulating circadian rhythm, immune enhancement, metabolism regulation, antioxidant, anti-aging, and anti-tumor effects. It can prevent cell death, reduce inflammation, block calcium channels, etc. In this review, we briefly discuss the neuroprotective role of melatonin against various NDDs via regulating autophagy, which could be a new field for future translational research and clinical studies to discover preventive or therapeutic agents for many NDDs.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Luo</LastName><ForeName>Fang</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Neurosurgery, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sandhu</LastName><ForeName>Aaron F</ForeName><Initials>AF</Initials><AffiliationInfo><Affiliation>Department of Neurosurgery, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rungratanawanich</LastName><ForeName>Wiramon</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Section of Molecular Pharmacology and Toxicology, Laboratory of Membrane Biochemistry and Biophysics, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Rockville, MD 20892, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Williams</LastName><ForeName>George E</ForeName><Initials>GE</Initials><AffiliationInfo><Affiliation>Department of Neurosurgery, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Akbar</LastName><ForeName>Mohammed</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Division of Neuroscience &amp; Behavior, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Rockville, MD 20852, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhou</LastName><ForeName>Shuanhu</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Departments of Orthopedic Surgery, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Song</LastName><ForeName>Byoung-Joon</ForeName><Initials>BJ</Initials><Identifier Source="ORCID">0000-0002-3954-3497</Identifier><AffiliationInfo><Affiliation>Section of Molecular Pharmacology and Toxicology, Laboratory of Membrane Biochemistry and Biophysics, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Rockville, MD 20892, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Xin</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Neurosurgery, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>NA</GrantID><Agency>Brigham and Women's Hospital BRI Fund to Sustain Research Excellence (to X.W.)</Agency><Country/></Grant><Grant><GrantID>NA</GrantID><Agency>the Gillian Reny Stepping Strong Center for Trauma Innovation (to S. Z.).</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>09</Month><Day>28</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Int J Mol Sci</MedlineTA><NlmUniqueID>101092791</NlmUniqueID><ISSNLinking>1422-0067</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000975">Antioxidants</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000071183">Autophagy-Related Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D018696">Neuroprotective Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>JL5DK93RCL</RegistryNumber><NameOfSubstance UI="D008550">Melatonin</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000375" MajorTopicYN="N">Aging</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000544" MajorTopicYN="N">Alzheimer Disease</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000975" MajorTopicYN="N">Antioxidants</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001343" MajorTopicYN="N">Autophagy</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000071183" MajorTopicYN="N">Autophagy-Related Proteins</DescriptorName><QualifierName UI="Q000819" MajorTopicYN="N">agonists</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002940" MajorTopicYN="N">Circadian Rhythm</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006816" MajorTopicYN="N">Huntington Disease</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008550" MajorTopicYN="N">Melatonin</DescriptorName><QualifierName UI="Q000096" MajorTopicYN="N">biosynthesis</QualifierName><QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009420" MajorTopicYN="N">Nervous System</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009474" MajorTopicYN="N">Neurons</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018696" MajorTopicYN="N">Neuroprotective Agents</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010300" MajorTopicYN="N">Parkinson Disease</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010870" MajorTopicYN="N">Pineal Gland</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Alzheimer&#x2019;s disease</Keyword><Keyword MajorTopicYN="N">Huntington&#x2019;s disease</Keyword><Keyword MajorTopicYN="N">Parkinson&#x2019;s disease</Keyword><Keyword MajorTopicYN="N">amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">autophagy</Keyword><Keyword MajorTopicYN="N">melatonin</Keyword><Keyword MajorTopicYN="N">neurodegenerative diseases</Keyword><Keyword MajorTopicYN="N">organophosphate-induced delayed neuropathy</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>8</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2020</Year><Month>9</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>9</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>10</Month><Day>1</Day><Hour>1</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>10</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>2</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32998479</ArticleId><ArticleId IdType="pmc">PMC7584015</ArticleId><ArticleId IdType="doi">10.3390/ijms21197174</ArticleId><ArticleId IdType="pii">ijms21197174</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Bobkova N.V., Poltavtseva R.A., Leonov S.V., Sukhikh G.T. Neuroregeneration, Regulation in Neurodegenerative Diseases and Aging. Biochem. Mosc. 2020;85:S108&#x2013;S130.</Citation><ArticleIdList><ArticleId IdType="pubmed">32087056</ArticleId></ArticleIdList></Reference><Reference><Citation>Dumurgier J., Tzourio C. Epidemiology of neurological diseases in older adults. Rev. Neurol. 2020 doi: 10.1016/j.neurol.2020.01.356. in press.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurol.2020.01.356</ArticleId><ArticleId IdType="pubmed">32145981</ArticleId></ArticleIdList></Reference><Reference><Citation>Peng B., Yang Q., BJoshi R., Liu Y., Akbar M., Song B.-J., Zhou S., Wang X. Role of Alcohol Drinking in Alzheimer&#x2019;s Disease, Parkinson&#x2019;s Disease, and Amyotrophic Lateral Sclerosis. Int. J. Mol. Sci. 2020;21:2316. doi: 10.3390/ijms21072316.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms21072316</ArticleId><ArticleId IdType="pmc">PMC7177420</ArticleId><ArticleId IdType="pubmed">32230811</ArticleId></ArticleIdList></Reference><Reference><Citation>Heemels M.-T. Neurodegenerative diseases. Nature. 2016;539:179. doi: 10.1038/539179a.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/539179a</ArticleId><ArticleId IdType="pubmed">27830810</ArticleId></ArticleIdList></Reference><Reference><Citation>Winklhofer K.F., Tatzelt J., Haass C. The two faces of protein misfolding, gain- and loss-of-function in neurodegenerative diseases. EMBO. 2008;27:336&#x2013;349.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2234348</ArticleId><ArticleId IdType="pubmed">18216876</ArticleId></ArticleIdList></Reference><Reference><Citation>Finkbeiner E., Haindl M., Raman N., Muller S. SUMO routes ribosome maturation. Nucleus. 2011;2:527&#x2013;532. doi: 10.4161/nucl.2.6.17604.</Citation><ArticleIdList><ArticleId IdType="doi">10.4161/nucl.2.6.17604</ArticleId><ArticleId IdType="pubmed">22064470</ArticleId></ArticleIdList></Reference><Reference><Citation>Rubinsztein D.C., Gestwicki J.E., Murphy L.O., Klionsky D.J. Potential therapeutic applications of autophagy. Nat. Rev. Drug Discov. 2007;6:304&#x2013;312.</Citation><ArticleIdList><ArticleId IdType="pubmed">17396135</ArticleId></ArticleIdList></Reference><Reference><Citation>Fuchs Y., Steller H. Live to die another way, modes of programmed cell death and the signals emanating from dying cells. Nat. Rev. Mol. Cell Biol. 2015;16:329&#x2013;344.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4511109</ArticleId><ArticleId IdType="pubmed">25991373</ArticleId></ArticleIdList></Reference><Reference><Citation>Cohen E., Paulsson J.F., Blinder P., Burstyn-Cohen T., Du D., Estepa G., Adame A., Pham H.M., Holzenberger M., Kelly J.W., et al. Reduced IGF-1 Signaling Delays Age-Associated Proteotoxicity in Mice. Cell. 2009;139:1157&#x2013;1169. doi: 10.1016/j.cell.2009.11.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2009.11.014</ArticleId><ArticleId IdType="pmc">PMC3017511</ArticleId><ArticleId IdType="pubmed">20005808</ArticleId></ArticleIdList></Reference><Reference><Citation>Soto C., Pritzkow S. Protein misfolding, aggregation, and conformational strains in neurodegenerative diseases. Nat. Neurosci. 2018;21:1332&#x2013;1340.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6432913</ArticleId><ArticleId IdType="pubmed">30250260</ArticleId></ArticleIdList></Reference><Reference><Citation>Stancu I.-C., Ferraiolo M., Terwel D., Dewachter I. Tau Interacting Proteins, Gaining Insight into the Roles of Tau in Health and Disease. Adv. Exp. Med. Biol. 2019;1184:145&#x2013;166.</Citation><ArticleIdList><ArticleId IdType="pubmed">32096036</ArticleId></ArticleIdList></Reference><Reference><Citation>Zakeri Z., Bursch W., Tenniswood M., Lockshin R.A. Cell death, programmed, apoptosis, necrosis, or other? Cell Death Differ. 1995;2:87&#x2013;96.</Citation><ArticleIdList><ArticleId IdType="pubmed">17180070</ArticleId></ArticleIdList></Reference><Reference><Citation>D&#x2019;Arcy M.S. Cell death, a review of the major forms of apoptosis, necrosis and autophagy. Cell Biol. Int. 2019;43:582&#x2013;592. doi: 10.1002/cbin.11137.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cbin.11137</ArticleId><ArticleId IdType="pubmed">30958602</ArticleId></ArticleIdList></Reference><Reference><Citation>Martin S.J., Henry C.M. Distinguishing between apoptosis, necrosis, necroptosis and other cell death modalities. Methods. 2013;61:87&#x2013;89. doi: 10.1016/j.ymeth.2013.06.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ymeth.2013.06.001</ArticleId><ArticleId IdType="pubmed">23768793</ArticleId></ArticleIdList></Reference><Reference><Citation>Galluzzi L., Vitale I., Aaronson S.A., Abrams J.M., Adam D., Agostinis P., Alnemri E.S., Altucci L., Amelio I., Andrews D.W., et al. Molecular mechanisms of cell death, recommendations of the Nomenclature Committee on Cell Death 2018. Cell Death Differ. 2018;25:486&#x2013;541. doi: 10.1038/s41418-017-0012-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41418-017-0012-4</ArticleId><ArticleId IdType="pmc">PMC5864239</ArticleId><ArticleId IdType="pubmed">29362479</ArticleId></ArticleIdList></Reference><Reference><Citation>Perez-Polo J.R., Foreman P.J., Jackson G.R., Shan D., Taglialatela G., Thorpe L.W., Werrbach-Perez K. Nerve growth factor and neuronal cell death. Mol. Neurobiol. 1990;4:57&#x2013;91. doi: 10.1007/BF02935585.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF02935585</ArticleId><ArticleId IdType="pubmed">2076219</ArticleId></ArticleIdList></Reference><Reference><Citation>Fleisher T.A. Apoptosis. Ann. Allergy Asthma Immunol. 1997;78:245&#x2013;249. doi: 10.1016/S1081-1206(10)63176-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1081-1206(10)63176-6</ArticleId><ArticleId IdType="pubmed">9087147</ArticleId></ArticleIdList></Reference><Reference><Citation>Elmore S. Apoptosis, a review of programmed cell death. Toxicol. Pathol. 2007;35:495&#x2013;516. doi: 10.1080/01926230701320337.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/01926230701320337</ArticleId><ArticleId IdType="pmc">PMC2117903</ArticleId><ArticleId IdType="pubmed">17562483</ArticleId></ArticleIdList></Reference><Reference><Citation>Pistritto G., Trisciuoglio D., Ceci C., Garufi A., D&#x2019;Orazi G. Apoptosis as anticancer mechanism, function and dysfunction of its modulators and targeted therapeutic strategies. Aging. 2016;8:603&#x2013;619. doi: 10.18632/aging.100934.</Citation><ArticleIdList><ArticleId IdType="doi">10.18632/aging.100934</ArticleId><ArticleId IdType="pmc">PMC4925817</ArticleId><ArticleId IdType="pubmed">27019364</ArticleId></ArticleIdList></Reference><Reference><Citation>Parzych K.R., Klionsky D.J. An Overview of Autophagy, Morphology, Mechanism, and Regulation. Antioxid. Redox Signal. 2014;20:460&#x2013;473. doi: 10.1089/ars.2013.5371.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/ars.2013.5371</ArticleId><ArticleId IdType="pmc">PMC3894687</ArticleId><ArticleId IdType="pubmed">23725295</ArticleId></ArticleIdList></Reference><Reference><Citation>Ravanan P., Srikumar I.F., Talwar P. Autophagy, The spotlight for cellular stress responses. Life Sci. 2017;188:53&#x2013;67.</Citation><ArticleIdList><ArticleId IdType="pubmed">28866100</ArticleId></ArticleIdList></Reference><Reference><Citation>Thangaraj A., Sil S., Tripathi A., Chivero E.T., Periyasamy P., Buch S. Targeting endoplasmic reticulum stress and autophagy as therapeutic approaches for neurological diseases. Int. Rev. Cell Mol. Biol. 2020;350:285&#x2013;325.</Citation><ArticleIdList><ArticleId IdType="pubmed">32138902</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang D., Peng Z., Ren G., Wang G. The different roles of selective autophagic protein degradation in mammalian cells. Oncotarget. 2015;6:37098&#x2013;37116.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4741918</ArticleId><ArticleId IdType="pubmed">26415220</ArticleId></ArticleIdList></Reference><Reference><Citation>Whitehead N.P. Enhanced autophagy as a potential mechanism for the improved physiological function by simvastatin in muscular dystrophy. Autophagy. 2016;12:705&#x2013;706.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4835971</ArticleId><ArticleId IdType="pubmed">26890413</ArticleId></ArticleIdList></Reference><Reference><Citation>Kobayashi S. Choose Delicately and Reuse Adequately, The Newly Revealed Process of Autophagy. Biol. Pharm. Bull. 2015;38:1098&#x2013;1103.</Citation><ArticleIdList><ArticleId IdType="pubmed">26235572</ArticleId></ArticleIdList></Reference><Reference><Citation>Klionsky D.J. Autophagy, from phenomenology to molecular understanding in less than a decade. Nat. Rev. Mol. Cell Biol. 2007;8:931&#x2013;937.</Citation><ArticleIdList><ArticleId IdType="pubmed">17712358</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang Y., Klionsky D.J. Autophagy and disease, unanswered questions. Cell Death Differ. 2020;27:858&#x2013;871.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7206137</ArticleId><ArticleId IdType="pubmed">31900427</ArticleId></ArticleIdList></Reference><Reference><Citation>Mizushima N., Levine B., Cuervo A.M., Klionsky D.J. Autophagy fights disease through cellular self-digestion. Nature. 2008;451:1069&#x2013;1075.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2670399</ArticleId><ArticleId IdType="pubmed">18305538</ArticleId></ArticleIdList></Reference><Reference><Citation>Levine B., Kroemer G. Biological Functions of Autophagy Genes, A Disease Perspective. Cell. 2019;176:11&#x2013;42.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6347410</ArticleId><ArticleId IdType="pubmed">30633901</ArticleId></ArticleIdList></Reference><Reference><Citation>Boya P., Reggiori F., Codogno P. Emerging regulation and functions of autophagy. Nat. Cell Biol. 2013;15:713&#x2013;720.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7097732</ArticleId><ArticleId IdType="pubmed">23817233</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou H., Wang J., Jiang J., Stavrovskaya I.G., Li M., Li W., Wu Q., Zhang X., Luo C., Zhou S., et al. N-acetyl-serotonin offers neuroprotection through inhibiting mitochondrial death pathways and autophagic activation in experimental models of ischemic injury. J. Neurosci. 2014;34:2967&#x2013;2978. doi: 10.1523/JNEUROSCI.1948-13.2014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.1948-13.2014</ArticleId><ArticleId IdType="pmc">PMC3929763</ArticleId><ArticleId IdType="pubmed">24553937</ArticleId></ArticleIdList></Reference><Reference><Citation>Nikoletopoulou V., Papandreou M.-E., Tavernarakis N. Autophagy in the physiology and pathology of the central nervous system. Cell Death Differ. 2015;22:398&#x2013;407. doi: 10.1038/cdd.2014.204.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/cdd.2014.204</ArticleId><ArticleId IdType="pmc">PMC4326580</ArticleId><ArticleId IdType="pubmed">25526091</ArticleId></ArticleIdList></Reference><Reference><Citation>Pickford F., Masliah E., Britschgi M., Lucin K., Narasimhan R., Jaeger P.A., Small S., Spencer B., Rockenstein E., Levine B., et al. The autophagy-related protein beclin 1 shows reduced expression in early Alzheimer disease and regulates amyloid beta accumulation in mice. J. Clin. Investig. 2008;118:2190&#x2013;2199.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2391284</ArticleId><ArticleId IdType="pubmed">18497889</ArticleId></ArticleIdList></Reference><Reference><Citation>Bernard A., Jin M., Xu Z., Klionsky D.J. A large-scale analysis of autophagy-related gene expression identifies new regulators of autophagy. Autophagy. 2015;11:2114&#x2013;2122. doi: 10.1080/15548627.2015.1099796.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/15548627.2015.1099796</ArticleId><ArticleId IdType="pmc">PMC4824583</ArticleId><ArticleId IdType="pubmed">26649943</ArticleId></ArticleIdList></Reference><Reference><Citation>Murakawa T., Okamoto K., Omiya S., Taneike M., Yamaguchi O., Otsu K. A Mammalian Mitophagy Receptor, Bcl2-L-13, Recruits the ULK1 Complex to Induce Mitophagy. Cell Rep. 2019;26:338&#x2013;345.e6. doi: 10.1016/j.celrep.2018.12.050.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2018.12.050</ArticleId><ArticleId IdType="pmc">PMC6326162</ArticleId><ArticleId IdType="pubmed">30625316</ArticleId></ArticleIdList></Reference><Reference><Citation>Zachari M., Ganley I.G. The mammalian ULK1 complex and autophagy initiation. Essays Biochem. 2017;61:585&#x2013;596.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5869855</ArticleId><ArticleId IdType="pubmed">29233870</ArticleId></ArticleIdList></Reference><Reference><Citation>Baskaran R., Poornima P., Priya L.B., Huang C.-Y., Padma V.V. Neferine prevents autophagy induced by hypoxia through activation of Akt/mTOR pathway and Nrf2 in muscle cells. Biomed. Pharmacother. 2016;83:1407&#x2013;1413. doi: 10.1016/j.biopha.2016.08.063.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biopha.2016.08.063</ArticleId><ArticleId IdType="pubmed">27583981</ArticleId></ArticleIdList></Reference><Reference><Citation>Kalai Selvi S., Vinoth A., Varadharajan T., Weng C.F., Vijaya Padma V. Neferine augments therapeutic efficacy of cisplatin through ROS- mediated non-canonical autophagy in human lung adenocarcinoma (A549 cells) Food Chem. Toxicol. 2017;103:28&#x2013;40. doi: 10.1016/j.fct.2017.02.020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.fct.2017.02.020</ArticleId><ArticleId IdType="pubmed">28223119</ArticleId></ArticleIdList></Reference><Reference><Citation>Decuypere J.-P., Parys J.B., Bultynck G. Regulation of the autophagic bcl-2/beclin 1 interaction. Cells. 2012;1:284&#x2013;312. doi: 10.3390/cells1030284.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells1030284</ArticleId><ArticleId IdType="pmc">PMC3901098</ArticleId><ArticleId IdType="pubmed">24710477</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu G., Rios L., Yan Z., Jasper A.M., Luera D., Luo S., Rao H. Autophagy regulator Atg9 is degraded by the proteasome. Biochem. Biophys. Res. Commun. 2020;522:254&#x2013;258. doi: 10.1016/j.bbrc.2019.11.089.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2019.11.089</ArticleId><ArticleId IdType="pmc">PMC6954321</ArticleId><ArticleId IdType="pubmed">31759633</ArticleId></ArticleIdList></Reference><Reference><Citation>Kang S., Shin K.D., Kim J.H., Chung T. Autophagy-related (ATG) 11, ATG9 and the phosphatidylinositol 3-kinase control ATG2-mediated formation of autophagosomes in Arabidopsis. Plant Cell Rep. 2018;37:653&#x2013;664. doi: 10.1007/s00299-018-2258-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00299-018-2258-9</ArticleId><ArticleId IdType="pubmed">29350244</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh S., Kumari R., Chinchwadkar S., Aher A., Matheshwaran S., Manjithaya R. Exocyst Subcomplex Functions in Autophagosome Biogenesis by Regulating Atg9 Trafficking. J. Mol. Biol. 2019;431:2821&#x2013;2834. doi: 10.1016/j.jmb.2019.04.048.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jmb.2019.04.048</ArticleId><ArticleId IdType="pmc">PMC6698439</ArticleId><ArticleId IdType="pubmed">31103773</ArticleId></ArticleIdList></Reference><Reference><Citation>Li W., Zhang L. Regulation of ATG and Autophagy Initiation. Adv. Exp. Med. Biol. 2019;1206:41&#x2013;65.</Citation><ArticleIdList><ArticleId IdType="pubmed">31776979</ArticleId></ArticleIdList></Reference><Reference><Citation>Dong G., Zhang Z., Duan K., Shi W., Huang R., Wang B., Luo L., Zhang Y., Ruan H., Huang H. Beclin 1 deficiency causes hepatic cell apoptosis via endoplasmic reticulum stress in zebrafish larvae. FEBS Lett. 2020;594:1155&#x2013;1165. doi: 10.1002/1873-3468.13712.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/1873-3468.13712</ArticleId><ArticleId IdType="pubmed">31823348</ArticleId></ArticleIdList></Reference><Reference><Citation>A&#x11f;u&#x15f; H.H., Yilmaz S., &#x15e;eng&#xf6;z C.O. Crosstalk between autophagy and apoptosis induced by camphor in Schizosaccharomyces pombe. Turk. J. Biol. 2019;43:382&#x2013;390. doi: 10.3906/biy-1908-11.</Citation><ArticleIdList><ArticleId IdType="doi">10.3906/biy-1908-11</ArticleId><ArticleId IdType="pmc">PMC6911262</ArticleId><ArticleId IdType="pubmed">31892813</ArticleId></ArticleIdList></Reference><Reference><Citation>Maejima Y., Isobe M., Sadoshima J. Regulation of autophagy by Beclin 1 in the heart. J. Mol. Cell Cardiol. 2016;95:19&#x2013;25. doi: 10.1016/j.yjmcc.2015.10.032.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.yjmcc.2015.10.032</ArticleId><ArticleId IdType="pmc">PMC4861696</ArticleId><ArticleId IdType="pubmed">26546165</ArticleId></ArticleIdList></Reference><Reference><Citation>Vega-Rub&#xed;n-de-Celis S. The Role of Beclin 1-Dependent Autophagy in Cancer. Biology. 2019;9:4. doi: 10.3390/biology9010004.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biology9010004</ArticleId><ArticleId IdType="pmc">PMC7168252</ArticleId><ArticleId IdType="pubmed">31877888</ArticleId></ArticleIdList></Reference><Reference><Citation>Towers C.G., Wodetzki D., Thorburn A. Autophagy-dependent cancer cells circumvent loss of the upstream regulator RB1CC1/FIP200 and loss of LC3 conjugation by similar mechanisms. Autophagy. 2020;16:1332&#x2013;1340. doi: 10.1080/15548627.2020.1741204.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/15548627.2020.1741204</ArticleId><ArticleId IdType="pmc">PMC7469620</ArticleId><ArticleId IdType="pubmed">32160093</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang M.-Q., Li J.-R., Peng Z.-G., Zhang J.-P. Differential Effects of Autophagy-Related 10 Protein on HCV Replication and Autophagy Flux Are Mediated by Its Cysteine44 and Cysteine135. Front. Immunol. 2018;9:2176. doi: 10.3389/fimmu.2018.02176.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2018.02176</ArticleId><ArticleId IdType="pmc">PMC6165859</ArticleId><ArticleId IdType="pubmed">30319633</ArticleId></ArticleIdList></Reference><Reference><Citation>Shams Nooraei M., Noori-Zadeh A., Darabi S., Rajaei F., Golmohammadi Z., Abbaszadeh H.A. Low Level of Autophagy-Related Gene 10 (ATG10) Expression in the 6-Hydroxydopamine Rat Model of Parkinson&#x2019;s Disease. Iran Biomed. J. 2018;22:15&#x2013;21.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5712380</ArticleId><ArticleId IdType="pubmed">28734275</ArticleId></ArticleIdList></Reference><Reference><Citation>Maruyama T., Noda N.N. Autophagy-regulating protease Atg4, structure, function, regulation and inhibition. J. Antibiot. 2017;71:72&#x2013;78. doi: 10.1038/ja.2017.104.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ja.2017.104</ArticleId><ArticleId IdType="pmc">PMC5799747</ArticleId><ArticleId IdType="pubmed">28901328</ArticleId></ArticleIdList></Reference><Reference><Citation>Agrotis A., Pengo N., Burden J.J., Ketteler R. Redundancy of human ATG4 protease isoforms in autophagy and LC3/GABARAP processing revealed in cells. Autophagy. 2019;15:976&#x2013;997. doi: 10.1080/15548627.2019.1569925.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/15548627.2019.1569925</ArticleId><ArticleId IdType="pmc">PMC6526816</ArticleId><ArticleId IdType="pubmed">30661429</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang W., Zeng C., Hu S., Wang L., Liu J. ATG3, a Target of miR-431-5p, Promotes Proliferation and Invasion of Colon Cancer via Promoting Autophagy. Cancer Manag. Res. 2019;11:10275&#x2013;10285. doi: 10.2147/CMAR.S226828.</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/CMAR.S226828</ArticleId><ArticleId IdType="pmc">PMC6911302</ArticleId><ArticleId IdType="pubmed">31849517</ArticleId></ArticleIdList></Reference><Reference><Citation>Frudd K., Burgoyne T., Burgoyne J.R. Oxidation of Atg3 and Atg7 mediates inhibition of autophagy. Nat. Commun. 2018;9:95. doi: 10.1038/s41467-017-02352-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-017-02352-z</ArticleId><ArticleId IdType="pmc">PMC5758830</ArticleId><ArticleId IdType="pubmed">29311554</ArticleId></ArticleIdList></Reference><Reference><Citation>Manirujjaman M., Ozaki I., Murata Y., Guo J., Xia J., Nishioka K., Perveen R., Takahashi H., Anzai K., Matsuhashi S. Degradation of the Tumor Suppressor PDCD4 Is Impaired by the Suppression of p62/SQSTM1 and Autophagy. Cells. 2020;9:218. doi: 10.3390/cells9010218.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells9010218</ArticleId><ArticleId IdType="pmc">PMC7016974</ArticleId><ArticleId IdType="pubmed">31952347</ArticleId></ArticleIdList></Reference><Reference><Citation>Liao W., Wang Z., Fu Z., Ma H., Jiang M., Xu A., Zhang W. p62/SQSTM1 protects against cisplatin-induced oxidative stress in kidneys by mediating the cross talk between autophagy and the Keap1-Nrf2 signalling pathway. Free Radic. Res. 2019;53:800&#x2013;814. doi: 10.1080/10715762.2019.1635251.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/10715762.2019.1635251</ArticleId><ArticleId IdType="pubmed">31223046</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y., Mun S.R., Linares J.F., Ahn J., Towers C.G., Ji C.H., Fitzwalter B.E., Holden M.R., Mi W., Shi X., et al. ZZ-dependent regulation of p62/SQSTM1 in autophagy. Nat. Commun. 2018;9:4373. doi: 10.1038/s41467-018-06878-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-018-06878-8</ArticleId><ArticleId IdType="pmc">PMC6197226</ArticleId><ArticleId IdType="pubmed">30349045</ArticleId></ArticleIdList></Reference><Reference><Citation>Aparicio R., Rana A., Walker D.W. Upregulation of the Autophagy Adaptor p62/SQSTM1 Prolongs Health and Lifespan in Middle-Aged Drosophila. Cell Rep. 2019;28:1029&#x2013;1040.e5. doi: 10.1016/j.celrep.2019.06.070.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2019.06.070</ArticleId><ArticleId IdType="pmc">PMC6688777</ArticleId><ArticleId IdType="pubmed">31340141</ArticleId></ArticleIdList></Reference><Reference><Citation>Deng Z., Purtell K., Lachance V., Wold M.S., Chen S., Yue Z. Autophagy Receptors and Neurodegenerative Diseases. Trends Cell Biol. 2017;27:491&#x2013;504. doi: 10.1016/j.tcb.2017.01.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tcb.2017.01.001</ArticleId><ArticleId IdType="pubmed">28169082</ArticleId></ArticleIdList></Reference><Reference><Citation>Mancias J.D., Kimmelman A.C. Mechanisms of Selective Autophagy in Normal Physiology and Cancer. J. Mol. Biol. 2016;428:1659&#x2013;1680. doi: 10.1016/j.jmb.2016.02.027.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jmb.2016.02.027</ArticleId><ArticleId IdType="pmc">PMC4846542</ArticleId><ArticleId IdType="pubmed">26953261</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaiser S.E., Qiu Y., Coats J.E., Mao K., Klionsky D.J., Schulman B.A. Structures of Atg7-Atg3 and Atg7-Atg10 reveal noncanonical mechanisms of E2 recruitment by the autophagy E1. Autophagy. 2013;9:778&#x2013;780. doi: 10.4161/auto.23644.</Citation><ArticleIdList><ArticleId IdType="doi">10.4161/auto.23644</ArticleId><ArticleId IdType="pmc">PMC3669186</ArticleId><ArticleId IdType="pubmed">23388412</ArticleId></ArticleIdList></Reference><Reference><Citation>Schulze-Luehrmann J., Eckart R.A., &#xd6;lke M., Saftig P., Liebler-Tenorio E., L&#xfc;hrmann A. LAMP proteins account for the maturation delay during the establishment of the Coxiella burnetii-containing vacuole. Cell Microbiol. 2016;18:181&#x2013;194. doi: 10.1111/cmi.12494.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/cmi.12494</ArticleId><ArticleId IdType="pubmed">26249821</ArticleId></ArticleIdList></Reference><Reference><Citation>Dikic I., Elazar Z. Mechanism and medical implications of mammalian autophagy. Nat. Rev. Mol. Cell Biol. 2018;19:349&#x2013;364. doi: 10.1038/s41580-018-0003-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41580-018-0003-4</ArticleId><ArticleId IdType="pubmed">29618831</ArticleId></ArticleIdList></Reference><Reference><Citation>Randhawa R., Sehgal M., Singh T.R., Duseja A., Changotra H. Unc-51 like kinase 1 (ULK1) in silico analysis for biomarker identification, a vital component of autophagy. Gene. 2015;562:40&#x2013;49. doi: 10.1016/j.gene.2015.02.056.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.gene.2015.02.056</ArticleId><ArticleId IdType="pubmed">25701603</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen G., Ke Z., Xu M., Liao M., Wang X., Qi Y., Zhang T., Frank J.A., Bower K.A., Shi X., et al. Autophagy is a protective response to ethanol neurotoxicity. Autophagy. 2012;8:1577&#x2013;1589. doi: 10.4161/auto.21376.</Citation><ArticleIdList><ArticleId IdType="doi">10.4161/auto.21376</ArticleId><ArticleId IdType="pmc">PMC3494588</ArticleId><ArticleId IdType="pubmed">22874567</ArticleId></ArticleIdList></Reference><Reference><Citation>Ge D., Tao H.-R., Fang L., Kong X.-Q., Han L.-N., Li N., Xu Y.-X., Li L.-Y., Yu M., Zhang H. 11-Methoxytabersonine Induces Necroptosis with Autophagy through AMPK/mTOR and JNK Pathways in Human Lung Cancer Cells. Chem. Pharm. Bull. 2020;68:244&#x2013;250. doi: 10.1248/cpb.c19-00851.</Citation><ArticleIdList><ArticleId IdType="doi">10.1248/cpb.c19-00851</ArticleId><ArticleId IdType="pubmed">32115531</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim J., Kundu M., Viollet B., Guan K.-L. AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1. Nat. Cell Biol. 2011;13:132&#x2013;141. doi: 10.1038/ncb2152.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncb2152</ArticleId><ArticleId IdType="pmc">PMC3987946</ArticleId><ArticleId IdType="pubmed">21258367</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan Y., Yin L., Sun Z., Shao S., Chen W., Man X., Du Y., Chen Y. Astragalus polysaccharide exerts anti-Parkinson via activating the PI3K/AKT/mTOR pathway to increase cellular autophagy level in vitro. Int. J. Biol. Macromol. 2020;153:349&#x2013;356. doi: 10.1016/j.ijbiomac.2020.02.282.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijbiomac.2020.02.282</ArticleId><ArticleId IdType="pubmed">32112840</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao Y., Feng X., Li B., Sha J., Wang C., Yang T., Cui H., Fan H. Dexmedetomidine Protects Against Lipopolysaccharide-Induced Acute Kidney Injury by Enhancing Autophagy Through Inhibition of the PI3K/AKT/mTOR Pathway. Front. Pharmacol. 2020;11:128. doi: 10.3389/fphar.2020.00128.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2020.00128</ArticleId><ArticleId IdType="pmc">PMC7052304</ArticleId><ArticleId IdType="pubmed">32158395</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim Y.C., Guan K.-L. mTOR, a pharmacologic target for autophagy regulation. J. Clin. Investig. 2015;125:25&#x2013;32. doi: 10.1172/JCI73939.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI73939</ArticleId><ArticleId IdType="pmc">PMC4382265</ArticleId><ArticleId IdType="pubmed">25654547</ArticleId></ArticleIdList></Reference><Reference><Citation>Qi Y., Cheng X., Gong G., Yan T., Du Y., Wu B., Bi K., Jia Y. Synergistic neuroprotective effect of schisandrin and nootkatone on regulating inflammation, apoptosis and autophagy via the PI3K/AKT pathway. Food Funct. 2020;11:2427&#x2013;2438. doi: 10.1039/C9FO02927C.</Citation><ArticleIdList><ArticleId IdType="doi">10.1039/C9FO02927C</ArticleId><ArticleId IdType="pubmed">32129354</ArticleId></ArticleIdList></Reference><Reference><Citation>Heras-Sandoval D., P&#xe9;rez-Rojas J.M., Hern&#xe1;ndez-Dami&#xe1;n J., Pedraza-Chaverri J. The role of PI3K/AKT/mTOR pathway in the modulation of autophagy and the clearance of protein aggregates in neurodegeneration. Cell Signal. 2014;26:2694&#x2013;2701. doi: 10.1016/j.cellsig.2014.08.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cellsig.2014.08.019</ArticleId><ArticleId IdType="pubmed">25173700</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu L., Chen Y., Tooze S.A. Autophagy pathway, Cellular and molecular mechanisms. Autophagy. 2018;14:207&#x2013;215. doi: 10.1080/15548627.2017.1378838.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/15548627.2017.1378838</ArticleId><ArticleId IdType="pmc">PMC5902171</ArticleId><ArticleId IdType="pubmed">28933638</ArticleId></ArticleIdList></Reference><Reference><Citation>You Z., Xu Y., Wan W., Zhou L., Li J., Zhou T., Shi Y., Liu W. TP53INP2 contributes to autophagosome formation by promoting LC3-ATG7 interaction. Autophagy. 2019;15:1309&#x2013;1321. doi: 10.1080/15548627.2019.1580510.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/15548627.2019.1580510</ArticleId><ArticleId IdType="pmc">PMC6613902</ArticleId><ArticleId IdType="pubmed">30767704</ArticleId></ArticleIdList></Reference><Reference><Citation>Saleeb R.S., Kavanagh D.M., Dun A.R., Dalgarno P.A., Duncan R.R. A VPS33A-binding motif on syntaxin 17 controls autophagy completion in mammalian cells. J. Biol. Chem. 2019;294:4188&#x2013;4201. doi: 10.1074/jbc.RA118.005947.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.RA118.005947</ArticleId><ArticleId IdType="pmc">PMC6422071</ArticleId><ArticleId IdType="pubmed">30655294</ArticleId></ArticleIdList></Reference><Reference><Citation>Tian X., Zheng P., Zhou C., Wang X., Ma H., Ma W., Zhou X., Teng J., Chen J. DIPK2A promotes STX17- and VAMP7-mediated autophagosome-lysosome fusion by binding to VAMP7B. Autophagy. 2019;16:797&#x2013;810. doi: 10.1080/15548627.2019.1637199.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/15548627.2019.1637199</ArticleId><ArticleId IdType="pmc">PMC7144865</ArticleId><ArticleId IdType="pubmed">31251111</ArticleId></ArticleIdList></Reference><Reference><Citation>Gomes L.R., Menck C.F.M., Leandro G.S. Autophagy Roles in the Modulation of DNA Repair Pathways. Int. J. Mol. Sci. 2017;18:2351. doi: 10.3390/ijms18112351.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms18112351</ArticleId><ArticleId IdType="pmc">PMC5713320</ArticleId><ArticleId IdType="pubmed">29112132</ArticleId></ArticleIdList></Reference><Reference><Citation>Hartl F.U. Protein Misfolding Diseases. Ann. Rev. Biochem. 2017;86:21&#x2013;26. doi: 10.1146/annurev-biochem-061516-044518.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-biochem-061516-044518</ArticleId><ArticleId IdType="pubmed">28441058</ArticleId></ArticleIdList></Reference><Reference><Citation>Falcon B., Zhang W., Murzin A.G., Murshudov G., Garringer H.J., Vidal R., Crowther R.A., Ghetti B., Scheres S.H.W., Goedert M. Structures of filaments from Pick&#x2019;s disease reveal a novel tau protein fold. Nature. 2018;561:137&#x2013;140. doi: 10.1038/s41586-018-0454-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-018-0454-y</ArticleId><ArticleId IdType="pmc">PMC6204212</ArticleId><ArticleId IdType="pubmed">30158706</ArticleId></ArticleIdList></Reference><Reference><Citation>Martinez-Lopez N., Athonvarangkul D., Singh R. Autophagy and aging. Adv. Exp. Med. Biol. 2015;847:73&#x2013;87.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4644734</ArticleId><ArticleId IdType="pubmed">25916586</ArticleId></ArticleIdList></Reference><Reference><Citation>Martinez-Lopez N., Garcia-Macia M., Sahu S., Athonvarangkul D., Liebling E., Merlo P., Cecconi F., Schwartz G.J., Singh R. Autophagy in the CNS and Periphery Coordinate Lipophagy and Lipolysis in the Brown Adipose Tissue and Liver. Cell Metab. 2016;23:113&#x2013;127. doi: 10.1016/j.cmet.2015.10.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmet.2015.10.008</ArticleId><ArticleId IdType="pmc">PMC4715637</ArticleId><ArticleId IdType="pubmed">26698918</ArticleId></ArticleIdList></Reference><Reference><Citation>Rahman M.A., Rhim H. Therapeutic implication of autophagy in neurodegenerative diseases. BMB Rep. 2017;50:345&#x2013;354. doi: 10.5483/BMBRep.2017.50.7.069.</Citation><ArticleIdList><ArticleId IdType="doi">10.5483/BMBRep.2017.50.7.069</ArticleId><ArticleId IdType="pmc">PMC5584741</ArticleId><ArticleId IdType="pubmed">28454606</ArticleId></ArticleIdList></Reference><Reference><Citation>Vervliet T. Ryanodine Receptors in Autophagy, Implications for Neurodegenerative Diseases? Front. Cell Neurosci. 2018;12:89. doi: 10.3389/fncel.2018.00089.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2018.00089</ArticleId><ArticleId IdType="pmc">PMC5880912</ArticleId><ArticleId IdType="pubmed">29636667</ArticleId></ArticleIdList></Reference><Reference><Citation>Bekris L.M., Yu C.-E., Bird T.D., Tsuang D.W. Genetics of Alzheimer Disease. J. Geriatr. Psychiatr. Neurol. 2010;23:213&#x2013;227. doi: 10.1177/0891988710383571.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0891988710383571</ArticleId><ArticleId IdType="pmc">PMC3044597</ArticleId><ArticleId IdType="pubmed">21045163</ArticleId></ArticleIdList></Reference><Reference><Citation>Friedrich R.P., Tepper K., R&#xf6;nicke R., Soom M., Westermann M., Reymann K., Kaether C., F&#xe4;ndrich M. Mechanism of amyloid plaque formation suggests an intracellular basis of A&#x3b2; pathogenicity. Proc. Natl. Acad. Sci. USA. 2010;107:1942&#x2013;1947. doi: 10.1073/pnas.0904532106.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0904532106</ArticleId><ArticleId IdType="pmc">PMC2836607</ArticleId><ArticleId IdType="pubmed">20133839</ArticleId></ArticleIdList></Reference><Reference><Citation>Cho Y.-E., Lee M.-H., Song B.-J. Neuronal Cell Death and Degeneration through Increased Nitroxidative Stress and Tau Phosphorylation in HIV-1 Transgenic Rats. PLoS ONE. 2017;12:e0169945. doi: 10.1371/journal.pone.0169945.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0169945</ArticleId><ArticleId IdType="pmc">PMC5249108</ArticleId><ArticleId IdType="pubmed">28107387</ArticleId></ArticleIdList></Reference><Reference><Citation>Henderson L.E., Abdelmegeed M.A., Yoo S.H., Rhee S.G., Zhu X., Smith M.A., Nguyen R.Q., Perry G., Song B.J. Enhanced Phosphorylation of Bax and Its Translocation into Mitochondria in the Brains of Individuals Affiliated with Alzheimer&#x2019;s Disease. Open Neurol. J. 2017;11:48&#x2013;58. doi: 10.2174/1874205X01711010048.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1874205X01711010048</ArticleId><ArticleId IdType="pmc">PMC5738752</ArticleId><ArticleId IdType="pubmed">29290835</ArticleId></ArticleIdList></Reference><Reference><Citation>Baranello R., Bharani K., Padmaraju V., Chopra N., Lahiri D., Greig N., Pappolla M., Sambamurti K. Amyloid-Beta Protein Clearance and Degradation (ABCD) Pathways and their Role in Alzheimer&#x2019;s Disease. CAR. 2015;12:32&#x2013;46. doi: 10.2174/1567205012666141218140953.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1567205012666141218140953</ArticleId><ArticleId IdType="pmc">PMC4820400</ArticleId><ArticleId IdType="pubmed">25523424</ArticleId></ArticleIdList></Reference><Reference><Citation>Pacheco-Quinto J., Clausen D., P&#xe9;rez-Gonz&#xe1;lez R., Peng H., Meszaros A., Eckman C.B., Levy E., Eckman E.A. Intracellular metalloprotease activity controls intraneuronal A&#x3b2; aggregation and limits secretion of A&#x3b2; via exosomes. FASEB J. 2019;33:3758&#x2013;3771. doi: 10.1096/fj.201801319R.</Citation><ArticleIdList><ArticleId IdType="doi">10.1096/fj.201801319R</ArticleId><ArticleId IdType="pmc">PMC6404562</ArticleId><ArticleId IdType="pubmed">30481490</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee J.-H., Wolfe D.M., Darji S., McBrayer M.K., Colacurcio D.J., Kumar A., Stavrides P., Mohan P.S., Nixon R.A. &#x3b2;2-adrenergic agonists rescue lysosome acidification and function in PSEN1 deficiency by reversing defective ER to lysosome delivery of ClC-7. J. Mol. Biol. 2020;432:2633&#x2013;2650. doi: 10.1016/j.jmb.2020.02.021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jmb.2020.02.021</ArticleId><ArticleId IdType="pmc">PMC7211125</ArticleId><ArticleId IdType="pubmed">32105735</ArticleId></ArticleIdList></Reference><Reference><Citation>Mart&#xed;n-Maestro P., Sproul A., Martinez H., Paquet D., Gerges M., Noggle S., Starkov A.A. Autophagy Induction by Bexarotene Promotes Mitophagy in Presenilin 1 Familial Alzheimer&#x2019;s Disease iPSC-Derived Neural Stem Cells. Mol. Neurobiol. 2019;56:8220&#x2013;8236. doi: 10.1007/s12035-019-01665-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-019-01665-y</ArticleId><ArticleId IdType="pmc">PMC6842097</ArticleId><ArticleId IdType="pubmed">31203573</ArticleId></ArticleIdList></Reference><Reference><Citation>Frake R.A., Ricketts T., Menzies F.M., Rubinsztein D.C. Autophagy and neurodegeneration. J. Clin. Investig. 2015;125:65&#x2013;74. doi: 10.1172/JCI73944.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI73944</ArticleId><ArticleId IdType="pmc">PMC4382230</ArticleId><ArticleId IdType="pubmed">25654552</ArticleId></ArticleIdList></Reference><Reference><Citation>Pendin D., Fasolato C., Basso E., Filadi R., Greotti E., Galla L., Gomiero C., Leparulo A., Redolfi N., Scremin E., et al. Familial Alzheimer&#x2019;s disease presenilin-2 mutants affect Ca2+ homeostasis and brain network excitability. Aging Clin. Exp. Res. 2019:1&#x2013;4. doi: 10.1007/s40520-019-01341-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40520-019-01341-0</ArticleId><ArticleId IdType="pubmed">31606858</ArticleId></ArticleIdList></Reference><Reference><Citation>Galla L., Redolfi N., Pozzan T., Pizzo P., Greotti E. Intracellular Calcium Dysregulation by the Alzheimer&#x2019;s Disease-Linked Protein Presenilin 2. Int. J. Mol. Sci. 2020;21:770. doi: 10.3390/ijms21030770.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms21030770</ArticleId><ArticleId IdType="pmc">PMC7037278</ArticleId><ArticleId IdType="pubmed">31991578</ArticleId></ArticleIdList></Reference><Reference><Citation>Oliver D.M.A., Reddy P.H. Molecular Basis of Alzheimer&#x2019;s Disease, Focus on Mitochondria. J. Alzheimers Dis. 2019;72:S95&#x2013;S116. doi: 10.3233/JAD-190048.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JAD-190048</ArticleId><ArticleId IdType="pubmed">30932888</ArticleId></ArticleIdList></Reference><Reference><Citation>Ando K., De Decker R., Vergara C., Yilmaz Z., Mansour S., Suain V., Sleegers K., de Fisenne M.-A., Houben S., Potier M.-C., et al. Picalm reduction exacerbates tau pathology in a murine tauopathy model. Acta Neuropathol. 2020;139:773&#x2013;789. doi: 10.1007/s00401-020-02125-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-020-02125-x</ArticleId><ArticleId IdType="pubmed">31925534</ArticleId></ArticleIdList></Reference><Reference><Citation>Moreau K., Fleming A., Imarisio S., Lopez Ramirez A., Mercer J.L., Jimenez-Sanchez M., Bento C.F., Puri C., Zavodszky E., Siddiqi F., et al. PICALM modulates autophagy activity and tau accumulation. Nat. Commun. 2014;5:4998. doi: 10.1038/ncomms5998.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms5998</ArticleId><ArticleId IdType="pmc">PMC4199285</ArticleId><ArticleId IdType="pubmed">25241929</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Acker Z.P., Bretou M., Annaert W. Endo-lysosomal dysregulations and late-onset Alzheimer&#x2019;s disease, impact of genetic risk factors. Mol. Neurodegener. 2019;14:20. doi: 10.1186/s13024-019-0323-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13024-019-0323-7</ArticleId><ArticleId IdType="pmc">PMC6547588</ArticleId><ArticleId IdType="pubmed">31159836</ArticleId></ArticleIdList></Reference><Reference><Citation>Ando K., Tomimura K., Sazdovitch V., Suain V., Yilmaz Z., Authelet M., Ndjim M., Vergara C., Belkouch M., Potier M.-C., et al. Level of PICALM, a key component of clathrin-mediated endocytosis, is correlated with levels of phosphotau and autophagy-related proteins and is associated with tau inclusions in AD, PSP and Pick disease. Neurobiol. Dis. 2016;94:32&#x2013;43. doi: 10.1016/j.nbd.2016.05.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2016.05.017</ArticleId><ArticleId IdType="pubmed">27260836</ArticleId></ArticleIdList></Reference><Reference><Citation>Roy K., Chakrabarti O., Mukhopadhyay D. Interaction of Grb2 SH3 domain with UVRAG in an Alzheimer&#x2019;s disease-like scenario. Biochem. Cell Biol. 2014;92:219&#x2013;225. doi: 10.1139/bcb-2014-0001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1139/bcb-2014-0001</ArticleId><ArticleId IdType="pubmed">24882360</ArticleId></ArticleIdList></Reference><Reference><Citation>Bieri G., Lucin K.M., O&#x2019;Brien C.E., Zhang H., Villeda S.A., Wyss-Coray T. Proteolytic cleavage of Beclin 1 exacerbates neurodegeneration. Mol. Neurodegener. 2018;13:68. doi: 10.1186/s13024-018-0302-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13024-018-0302-4</ArticleId><ArticleId IdType="pmc">PMC6310967</ArticleId><ArticleId IdType="pubmed">30594228</ArticleId></ArticleIdList></Reference><Reference><Citation>Wani A., Gupta M., Ahmad M., Shah A.M., Ahsan A.U., Qazi P.H., Malik F., Singh G., Sharma P.R., Kaddoumi A., et al. Alborixin clears amyloid-&#x3b2; by inducing autophagy through PTEN-mediated inhibition of the AKT pathway. Autophagy. 2019;15:1810&#x2013;1828. doi: 10.1080/15548627.2019.1596476.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/15548627.2019.1596476</ArticleId><ArticleId IdType="pmc">PMC6735498</ArticleId><ArticleId IdType="pubmed">30894052</ArticleId></ArticleIdList></Reference><Reference><Citation>Lucin K.M., O&#x2019;Brien C.E., Bieri G., Czirr E., Mosher K.I., Abbey R.J., Mastroeni D.F., Rogers J., Spencer B., Masliah E., et al. Microglial beclin 1 regulates retromer trafficking and phagocytosis and is impaired in Alzheimer&#x2019;s disease. Neuron. 2013;79:873&#x2013;886. doi: 10.1016/j.neuron.2013.06.046.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2013.06.046</ArticleId><ArticleId IdType="pmc">PMC3779465</ArticleId><ArticleId IdType="pubmed">24012002</ArticleId></ArticleIdList></Reference><Reference><Citation>Song L., Yao L., Zhang L., Piao Z., Lu Y. Schizandrol A protects against A&#x3b2;1-42-induced autophagy via activation of PI3K/AKT/mTOR pathway in SH-SY5Y cells and primary hippocampal neurons. Naunyn. Schmiedebergs Arch Pharmacol. 2020;393:1739&#x2013;1752. doi: 10.1007/s00210-019-01792-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00210-019-01792-2</ArticleId><ArticleId IdType="pubmed">31900522</ArticleId></ArticleIdList></Reference><Reference><Citation>Mueed Z., Tandon P., Maurya S.K., Deval R., Kamal M.A., Poddar N.K. Tau and mTOR, The Hotspots for Multifarious Diseases in Alzheimer&#x2019;s Development. Front. Neurosci. 2018;12:1017. doi: 10.3389/fnins.2018.01017.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2018.01017</ArticleId><ArticleId IdType="pmc">PMC6335350</ArticleId><ArticleId IdType="pubmed">30686983</ArticleId></ArticleIdList></Reference><Reference><Citation>Vartak R.S., Rodin A., Oddo S. Differential activation of the mTOR/autophagy pathway predicts cognitive performance in APP/PS1 mice. Neurobiol. Aging. 2019;83:105&#x2013;113. doi: 10.1016/j.neurobiolaging.2019.08.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2019.08.018</ArticleId><ArticleId IdType="pubmed">31585361</ArticleId></ArticleIdList></Reference><Reference><Citation>Cassano T., Magini A., Giovagnoli S., Polchi A., Calcagnini S., Pace L., Lavecchia M.A., Scuderi C., Bronzuoli M.R., Ruggeri L., et al. Early intrathecal infusion of everolimus restores cognitive function and mood in a murine model of Alzheimer&#x2019;s disease. Exp. Neurol. 2019;311:88&#x2013;105. doi: 10.1016/j.expneurol.2018.09.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.expneurol.2018.09.011</ArticleId><ArticleId IdType="pubmed">30243986</ArticleId></ArticleIdList></Reference><Reference><Citation>Caccamo A., Belfiore R., Oddo S. Genetically reducing mTOR signaling rescues central insulin dysregulation in a mouse model of Alzheimer&#x2019;s disease. Neurobiol. Aging. 2018;68:59&#x2013;67. doi: 10.1016/j.neurobiolaging.2018.03.032.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2018.03.032</ArticleId><ArticleId IdType="pmc">PMC6777740</ArticleId><ArticleId IdType="pubmed">29729422</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie Y., Zhou B., Lin M.-Y., Sheng Z.-H. Progressive endolysosomal deficits impair autophagic clearance beginning at early asymptomatic stages in fALS mice. Autophagy. 2015;11:1934&#x2013;1936. doi: 10.1080/15548627.2015.1084460.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/15548627.2015.1084460</ArticleId><ArticleId IdType="pmc">PMC4824580</ArticleId><ArticleId IdType="pubmed">26290961</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang L., Lin M., Zhong X., Yang H., Deng M. Galangin decreases p-tau, A&#x3b2;42 and &#x3b2;-secretase levels, and suppresses autophagy in okadaic acid-induced PC12 cells via an Akt/GSK3&#x3b2;/mTOR signaling-dependent mechanism. Mol. Med. Rep. 2019;19:1767&#x2013;1774. doi: 10.3892/mmr.2019.9824.</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/mmr.2019.9824</ArticleId><ArticleId IdType="pubmed">30628698</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Domenico F., Tramutola A., Foppoli C., Head E., Perluigi M., Butterfield D.A. mTOR in Down syndrome, Role in A&#xdf; and tau neuropathology and transition to Alzheimer disease-like dementia. Free Radic. Biol. Med. 2018;114:94&#x2013;101. doi: 10.1016/j.freeradbiomed.2017.08.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.freeradbiomed.2017.08.009</ArticleId><ArticleId IdType="pmc">PMC5748251</ArticleId><ArticleId IdType="pubmed">28807816</ArticleId></ArticleIdList></Reference><Reference><Citation>Shen W.-C., Li H.-Y., Chen G.-C., Chern Y., Tu P.-H. Mutations in the ubiquitin-binding domain of OPEN/optineurin interfere with autophagy-mediated degradation of misfolded proteins by a dominant-negative mechanism. Autophagy. 2015;11:685&#x2013;700. doi: 10.4161/auto.36098.</Citation><ArticleIdList><ArticleId IdType="doi">10.4161/auto.36098</ArticleId><ArticleId IdType="pmc">PMC4502753</ArticleId><ArticleId IdType="pubmed">25484089</ArticleId></ArticleIdList></Reference><Reference><Citation>Khaminets A., Behl C., Dikic I. Ubiquitin-Dependent and Independent Signals In Selective Autophagy. Trends Cell Biol. 2016;26:6&#x2013;16. doi: 10.1016/j.tcb.2015.08.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tcb.2015.08.010</ArticleId><ArticleId IdType="pubmed">26437584</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang C., Cai C.-Z., Song J.-X., Tan J.-Q., Durairajan S.S.K., Iyaswamy A., Wu M.-Y., Chen L.-L., Yue Z., Li M., et al. H. NRBF2 is involved in the autophagic degradation process of APP-CTFs in Alzheimer disease models. Autophagy. 2017;13:2028&#x2013;2040. doi: 10.1080/15548627.2017.1379633.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/15548627.2017.1379633</ArticleId><ArticleId IdType="pmc">PMC5788544</ArticleId><ArticleId IdType="pubmed">28980867</ArticleId></ArticleIdList></Reference><Reference><Citation>Kurosawa M., Matsumoto G., Sumikura H., Hatsuta H., Murayama S., Sakurai T., Shimogori T., Hattori N., Nukina N. Serine 403-phosphorylated p62/SQSTM1 immunoreactivity in inclusions of neurodegenerative diseases. Neurosci. Res. 2016;103:64&#x2013;70. doi: 10.1016/j.neures.2015.08.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neures.2015.08.002</ArticleId><ArticleId IdType="pubmed">26302676</ArticleId></ArticleIdList></Reference><Reference><Citation>Anthony Jalin A.M.A., Jin R., Wang M., Li G. EPPS treatment attenuates traumatic brain injury in mice by reducing A&#x3b2; burden and ameliorating neuronal autophagic flux. Exp. Neurol. 2019;314:20&#x2013;33. doi: 10.1016/j.expneurol.2019.01.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.expneurol.2019.01.002</ArticleId><ArticleId IdType="pmc">PMC6457462</ArticleId><ArticleId IdType="pubmed">30639321</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim S., Lee D., Song J.C., Cho S.-J., Yun S.-M., Koh Y.H., Song J., Johnson G.V.W., Jo C. NDP52 associates with phosphorylated tau in brains of an Alzheimer disease mouse model. Biochem. Biophys. Res. Commun. 2014;454:196&#x2013;201. doi: 10.1016/j.bbrc.2014.10.066.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2014.10.066</ArticleId><ArticleId IdType="pubmed">25450380</ArticleId></ArticleIdList></Reference><Reference><Citation>Woo J.-A.A., Liu T., Fang C.C., Casta&#xf1;o M.A., Kee T., Yrigoin K., Yan Y., Cazzaro S., Matlack J., Wang X., et al. &#x3b2;-Arrestin2 oligomers impair the clearance of pathological tau and increase tau aggregates. Proc. Natl. Acad. Sci. USA. 2020;117:5006&#x2013;5015. doi: 10.1073/pnas.1917194117.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1917194117</ArticleId><ArticleId IdType="pmc">PMC7060747</ArticleId><ArticleId IdType="pubmed">32071246</ArticleId></ArticleIdList></Reference><Reference><Citation>Tanji K., Miki Y., Ozaki T., Maruyama A., Yoshida H., Mimura J., Matsumiya T., Mori F., Imaizumi T., Itoh K., et al. Phosphorylation of serine 349 of p62 in Alzheimer&#x2019;s disease brain. Acta Neuropathol. Commun. 2014;2:50. doi: 10.1186/2051-5960-2-50.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/2051-5960-2-50</ArticleId><ArticleId IdType="pmc">PMC4035093</ArticleId><ArticleId IdType="pubmed">24886973</ArticleId></ArticleIdList></Reference><Reference><Citation>Akbar M., Essa M.M., Daradkeh G., Abdelmegeed M.A., Choi Y.S., Mahmood L., Song B.J. Mitochondrial Dysfunction and Cell Death in Neurodegenerative Diseases through Nitroxidative Stress. Brain Res. 2016;1637:34&#x2013;55. doi: 10.1016/j.brainres.2016.02.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainres.2016.02.016</ArticleId><ArticleId IdType="pmc">PMC4821765</ArticleId><ArticleId IdType="pubmed">26883165</ArticleId></ArticleIdList></Reference><Reference><Citation>Mizushima N. Autophagy, process and function. Genes Dev. 2007;21:2861&#x2013;2873.</Citation><ArticleIdList><ArticleId IdType="pubmed">18006683</ArticleId></ArticleIdList></Reference><Reference><Citation>Barnett R. Parkinson&#x2019;s disease. Lancet. 2016;387:217.</Citation><ArticleIdList><ArticleId IdType="pubmed">26842286</ArticleId></ArticleIdList></Reference><Reference><Citation>Grayson M. Parkinson&#x2019;s disease. Nature. 2016;538:S1. doi: 10.1038/538S1a.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/538S1a</ArticleId><ArticleId IdType="pubmed">27783582</ArticleId></ArticleIdList></Reference><Reference><Citation>Hijaz B.A., Volpicelli-Daley L.A. Initiation and propagation of &#x3b1;-synuclein aggregation in the nervous system. Mol. Neurodegener. 2020;15:19.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7060612</ArticleId><ArticleId IdType="pubmed">32143659</ArticleId></ArticleIdList></Reference><Reference><Citation>Pozo Devoto V.M., Falzone T.L. Mitochondrial dynamics in Parkinson&#x2019;s disease, a role for &#x3b1;-synuclein? Dis. Model Mech. 2017;10:1075&#x2013;1087.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5611962</ArticleId><ArticleId IdType="pubmed">28883016</ArticleId></ArticleIdList></Reference><Reference><Citation>Visanji N.P., Brotchie J.M., Kalia L.V., Koprich J.B., Tandon A., Watts J.C., Lang A.E. &#x3b1;-Synuclein-Based Animal Models of Parkinson&#x2019;s Disease, Challenges and Opportunities in a New Era. Trends Neurosci. 2016;39:750&#x2013;762.</Citation><ArticleIdList><ArticleId IdType="pubmed">27776749</ArticleId></ArticleIdList></Reference><Reference><Citation>Wakabayashi K., Tanji K., Mori F., Takahashi H. The Lewy body in Parkinson&#x2019;s disease, molecules implicated in the formation and degradation of alpha-synuclein aggregates. Neuropathology. 2007;27:494&#x2013;506.</Citation><ArticleIdList><ArticleId IdType="pubmed">18018486</ArticleId></ArticleIdList></Reference><Reference><Citation>An W.-L., Cowburn R.F., Li L., Braak H., Alafuzoff I., Iqbal K., Iqbal I.-G., Winblad B., Pei J.-J. Up-regulation of phosphorylated/activated p70 S6 kinase and its relationship to neurofibrillary pathology in Alzheimer&#x2019;s disease. Am. J. Pathol. 2003;163:591&#x2013;607.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1868198</ArticleId><ArticleId IdType="pubmed">12875979</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu C.-Y., Kang W.-Y., Chen Y.-M., Jiang T.-F., Zhang J., Zhang L.-N., Ding J.-Q., Liu J., Chen S.-D. DJ-1 Inhibits &#x3b1;-Synuclein Aggregation by Regulating Chaperone-Mediated Autophagy. Front. Aging Neurosci. 2017;9:308.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5623690</ArticleId><ArticleId IdType="pubmed">29021755</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun L., Lian Y., Ding J., Meng Y., Li C., Chen L., Qiu P. The role of chaperone-mediated autophagy in neurotoxicity induced by alpha-synuclein after methamphetamine exposure. Brain Behav. 2019;9:e01352.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6710200</ArticleId><ArticleId IdType="pubmed">31286692</ArticleId></ArticleIdList></Reference><Reference><Citation>Hunn B.H.M., Vingill S., Threlfell S., Alegre-Abarrategui J., Magdelyns M., Deltheil T., Bengoa-Vergniory N., Oliver P.L., Cioroch M., Doig N.M., et al. Impairment of Macroautophagy in Dopamine Neurons Has Opposing Effects on Parkinsonian Pathology and Behavior. Cell Rep. 2019;29:920&#x2013;931.e7. doi: 10.1016/j.celrep.2019.09.029.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2019.09.029</ArticleId><ArticleId IdType="pmc">PMC6856726</ArticleId><ArticleId IdType="pubmed">31644913</ArticleId></ArticleIdList></Reference><Reference><Citation>di Domenico A., Carola G., Calatayud C., Pons-Espinal M., Mu&#xf1;oz J.P., Richaud-Patin Y., Fernandez-Carasa I., Gut M., Faella A., Parameswaran J., et al. Patient-Specific iPSC-Derived Astrocytes Contribute to Non-Cell-Autonomous Neurodegeneration in Parkinson&#x2019;s Disease. Stem Cell Rep. 2019;12:213&#x2013;229. doi: 10.1016/j.stemcr.2018.12.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.stemcr.2018.12.011</ArticleId><ArticleId IdType="pmc">PMC6372974</ArticleId><ArticleId IdType="pubmed">30639209</ArticleId></ArticleIdList></Reference><Reference><Citation>Winslow A.R., Chen C.-W., Corrochano S., Acevedo-Arozena A., Gordon D.E., Peden A.A., Lichtenberg M., Menzies F.M., Ravikumar B., Imarisio S., et al. &#x3b1;-Synuclein impairs macroautophagy, implications for Parkinson&#x2019;s disease. J. Cell Biol. 2010;190:1023&#x2013;1037. doi: 10.1083/jcb.201003122.</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.201003122</ArticleId><ArticleId IdType="pmc">PMC3101586</ArticleId><ArticleId IdType="pubmed">20855506</ArticleId></ArticleIdList></Reference><Reference><Citation>Kam T.-I., Mao X., Park H., Chou S.-C., Karuppagounder S.S., Umanah G.E., Yun S.P., Brahmachari S., Panicker N., Chen R., et al. Poly(ADP-ribose) drives pathologic &#x3b1;-synuclein neurodegeneration in Parkinson&#x2019;s disease. Science. 2018;362:eaat8407. doi: 10.1126/science.aat8407.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aat8407</ArticleId><ArticleId IdType="pmc">PMC6431793</ArticleId><ArticleId IdType="pubmed">30385548</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang N., Chen Y., Jiang R., Li E., Chen X., Xi Z., Guo Y., Liu X., Zhou Y., Che Y., et al. PARP and RIP 1 are required for autophagy induced by 11&#x2019;-deoxyverticillin A, which precees capase-dependent apoptosis. Autophagy. 2011;7:598&#x2013;612. doi: 10.4161/auto.7.6.15103.</Citation><ArticleIdList><ArticleId IdType="doi">10.4161/auto.7.6.15103</ArticleId><ArticleId IdType="pubmed">21460625</ArticleId></ArticleIdList></Reference><Reference><Citation>Gugliandolo A., Pollastro F., Bramanti P., Mazzon E. Cannabidiol exerts protective effects in an in vitro model of Parkinson&#x2019;s disease activating AKT/mTOR pathway. Fitoterapia. 2020;143:104553. doi: 10.1016/j.fitote.2020.104553.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.fitote.2020.104553</ArticleId><ArticleId IdType="pubmed">32184097</ArticleId></ArticleIdList></Reference><Reference><Citation>Olsen A.L., Feany M.B. PARP Inhibitors and Parkinson&#x2019;s Disease. N. Engl. J. Med. 2019;380:492&#x2013;494. doi: 10.1056/NEJMcibr1814680.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMcibr1814680</ArticleId><ArticleId IdType="pubmed">30699325</ArticleId></ArticleIdList></Reference><Reference><Citation>Pan B., Petersson E.J. A PARP-1 Feed-Forward Mechanism to Accelerate &#x3b1;-Synuclein Toxicity in Parkinson&#x2019;s Disease. Biochemistry. 2019;58:859&#x2013;860. doi: 10.1021/acs.biochem.8b01311.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.biochem.8b01311</ArticleId><ArticleId IdType="pubmed">30776897</ArticleId></ArticleIdList></Reference><Reference><Citation>Vermilyea S.C., Babinski A., Tran N., To S., Guthrie S., Kluss J.H., Schmidt J.K., Wiepz G.J., Meyer M.G., Murphy M.E., et al. In Vitro CRISPR/Cas9-Directed Gene Editing to Model LRRK2 G2019S Parkinson&#x2019;s Disease in Common Marmosets. Sci. Rep. 2020;10:3447. doi: 10.1038/s41598-020-60273-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-020-60273-2</ArticleId><ArticleId IdType="pmc">PMC7044232</ArticleId><ArticleId IdType="pubmed">32103062</ArticleId></ArticleIdList></Reference><Reference><Citation>Hwang C.J., Kim Y.E., Son D.J., Park M.H., Choi D.-Y., Park P.-H., Hellstr&#xf6;m M., Han S.-B., Oh K.-W., Park E.K., et al. Parkin deficiency exacerbate ethanol-induced dopaminergic neurodegeneration by P38 pathway dependent inhibition of autophagy and mitochondrial function. Redox Biol. 2017;11:456&#x2013;468. doi: 10.1016/j.redox.2016.12.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.redox.2016.12.008</ArticleId><ArticleId IdType="pmc">PMC5226672</ArticleId><ArticleId IdType="pubmed">28086194</ArticleId></ArticleIdList></Reference><Reference><Citation>Meka D.P., M&#xfc;ller-Rischart A.K., Nidadavolu P., Mohammadi B., Motori E., Ponna S.K., Aboutalebi H., Bassal M., Annamneedi A., Finckh B., et al. Parkin cooperates with GDNF/RET signaling to prevent dopaminergic neuron degeneration. J. Clin. Investig. 2015;125:1873&#x2013;1885. doi: 10.1172/JCI79300.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI79300</ArticleId><ArticleId IdType="pmc">PMC4611569</ArticleId><ArticleId IdType="pubmed">25822020</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller S., Muqit M.M.K. Therapeutic approaches to enhance PINK1/Parkin mediated mitophagy for the treatment of Parkinson&#x2019;s disease. Neurosci. Lett. 2019;705:7&#x2013;13. doi: 10.1016/j.neulet.2019.04.029.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neulet.2019.04.029</ArticleId><ArticleId IdType="pubmed">30995519</ArticleId></ArticleIdList></Reference><Reference><Citation>Sauv&#xe9; V., Sung G., Soya N., Kozlov G., Blaimschein N., Miotto L.S., Trempe J.-F., Lukacs G.L., Gehring K. Mechanism of parkin activation by phosphorylation. Nat. Struct. Mol. Biol. 2018;25:623&#x2013;630. doi: 10.1038/s41594-018-0088-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41594-018-0088-7</ArticleId><ArticleId IdType="pubmed">29967542</ArticleId></ArticleIdList></Reference><Reference><Citation>Du T.-T., Wang L., Duan C.-L., Lu L.-L., Zhang J.-L., Gao G., Qiu X.-B., Wang X.-M., Yang H. GBA deficiency promotes SNCA/&#x3b1;-synuclein accumulation through autophagic inhibition by inactivated PPP2A. Autophagy. 2015;11:1803&#x2013;1820. doi: 10.1080/15548627.2015.1086055.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/15548627.2015.1086055</ArticleId><ArticleId IdType="pmc">PMC4824589</ArticleId><ArticleId IdType="pubmed">26378614</ArticleId></ArticleIdList></Reference><Reference><Citation>Gonzalez A., Valeiras M., Sidransky E., Tayebi N. Lysosomal integral membrane protein-2, a new player in lysosome-related pathology. Mol. Genet. Metab. 2014;111:84&#x2013;91. doi: 10.1016/j.ymgme.2013.12.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ymgme.2013.12.005</ArticleId><ArticleId IdType="pmc">PMC3924958</ArticleId><ArticleId IdType="pubmed">24389070</ArticleId></ArticleIdList></Reference><Reference><Citation>Balke D., Tatenhorst L., Dambeck V., Ribas V.T., Vahsen B.F., Michel U., B&#xe4;hr M., Lingor P. AAV-Mediated Expression of Dominant-Negative ULK1 Increases Neuronal Survival and Enhances Motor Performance in the MPTP Mouse Model of Parkinson&#x2019;s Disease. Mol. Neurobiol. 2020;57:685&#x2013;697. doi: 10.1007/s12035-019-01744-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-019-01744-0</ArticleId><ArticleId IdType="pubmed">31446549</ArticleId></ArticleIdList></Reference><Reference><Citation>Jodeiri Farshbaf M., Ghaedi K. Does any drug to treat cancer target mTOR and iron hemostasis in neurodegenerative disorders? Biometals. 2017;30:1&#x2013;16. doi: 10.1007/s10534-016-9981-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10534-016-9981-x</ArticleId><ArticleId IdType="pubmed">27853903</ArticleId></ArticleIdList></Reference><Reference><Citation>Ren Z.-L., Wang C.-D., Wang T., Ding H., Zhou M., Yang N., Liu Y.-Y., Chan P. Ganoderma lucidum extract ameliorates MPTP-induced parkinsonism and protects dopaminergic neurons from oxidative stress via regulating mitochondrial function, autophagy, and apoptosis. Acta Pharmacol. Sin. 2019;40:441&#x2013;450. doi: 10.1038/s41401-018-0077-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41401-018-0077-8</ArticleId><ArticleId IdType="pmc">PMC6461997</ArticleId><ArticleId IdType="pubmed">29991712</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu F., Fan M., Xu Z., Cai Y., Chen Y., Yu S., Zeng L. Neuroprotective effect of rapamycin against Parkinson&#x2019;s disease in mice. Zhejiang Da Xue Xue Bao Yi Xue Ban. 2018;47:465&#x2013;472.</Citation><ArticleIdList><ArticleId IdType="pubmed">30693687</ArticleId></ArticleIdList></Reference><Reference><Citation>Nicklin P., Bergman P., Zhang B., Triantafellow E., Wang H., Nyfeler B., Yang H., Hild M., Kung C., Wilson C., et al. Bidirectional transport of amino acids regulates mTOR and autophagy. Cell. 2009;136:521&#x2013;534. doi: 10.1016/j.cell.2008.11.044.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2008.11.044</ArticleId><ArticleId IdType="pmc">PMC3733119</ArticleId><ArticleId IdType="pubmed">19203585</ArticleId></ArticleIdList></Reference><Reference><Citation>Orr H.T. Beyond the Qs in the polyglutamine diseases. Genes Dev. 2001;15:925&#x2013;932. doi: 10.1101/gad.888401.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/gad.888401</ArticleId><ArticleId IdType="pubmed">11316786</ArticleId></ArticleIdList></Reference><Reference><Citation>Cepeda C., Tong X.-P. Huntington&#x2019;s disease, from basic science to therapeutics. CNS Neurosci. Ther. 2018;24:247&#x2013;249. doi: 10.1111/cns.12841.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/cns.12841</ArticleId><ArticleId IdType="pmc">PMC6489829</ArticleId><ArticleId IdType="pubmed">29582586</ArticleId></ArticleIdList></Reference><Reference><Citation>Yhnell E. Huntington&#x2019;s disease, of mice and men. Oncotarget. 2017;8:12552&#x2013;12553. doi: 10.18632/oncotarget.15129.</Citation><ArticleIdList><ArticleId IdType="doi">10.18632/oncotarget.15129</ArticleId><ArticleId IdType="pmc">PMC5355033</ArticleId><ArticleId IdType="pubmed">28184021</ArticleId></ArticleIdList></Reference><Reference><Citation>Franco-Iborra S., Plaza-Zabala A., Montpeyo M., Sebastian D., Vila M., Martinez-Vicente M. Mutant HTT (huntingtin) impairs mitophagy in a cellular model of Huntington disease. Autophagy. 2020:1&#x2013;18. doi: 10.1080/15548627.2020.1728096.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/15548627.2020.1728096</ArticleId><ArticleId IdType="pubmed">32093570</ArticleId></ArticleIdList></Reference><Reference><Citation>Luis-Ravelo D., Est&#xe9;vez-Silva H., Barroso-Chinea P., Afonso-Oramas D., Salas-Hern&#xe1;ndez J., Rodr&#xed;guez-N&#xfa;&#xf1;ez J., Acevedo-Arozena A., Marcellino D., Gonz&#xe1;lez-Hern&#xe1;ndez T. Pramipexole reduces soluble mutant huntingtin and protects striatal neurons through dopamine D3 receptors in a genetic model of Huntington&#x2019;s disease. Exp. Neurol. 2018;299:137&#x2013;147. doi: 10.1016/j.expneurol.2017.10.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.expneurol.2017.10.019</ArticleId><ArticleId IdType="pubmed">29056363</ArticleId></ArticleIdList></Reference><Reference><Citation>Martinez-Vicente M., Talloczy Z., Wong E., Tang G., Koga H., Kaushik S., de Vries R., Arias E., Harris S., Sulzer D., et al. Cargo recognition failure is responsible for inefficient autophagy in Huntington&#x2019;s disease. Nat. Neurosci. 2010;13:567&#x2013;576. doi: 10.1038/nn.2528.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.2528</ArticleId><ArticleId IdType="pmc">PMC2860687</ArticleId><ArticleId IdType="pubmed">20383138</ArticleId></ArticleIdList></Reference><Reference><Citation>Walter C., Clemens L.E., M&#xfc;ller A.J., Fallier-Becker P., Proikas-Cezanne T., Riess O., Metzger S., Nguyen H.P. Activation of AMPK-induced autophagy ameliorates Huntington disease pathology in vitro. Neuropharmacology. 2016;108:24&#x2013;38. doi: 10.1016/j.neuropharm.2016.04.041.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuropharm.2016.04.041</ArticleId><ArticleId IdType="pubmed">27133377</ArticleId></ArticleIdList></Reference><Reference><Citation>Wold M.S., Lim J., Lachance V., Deng Z., Yue Z. ULK1-mediated phosphorylation of ATG14 promotes autophagy and is impaired in Huntington&#x2019;s disease models. Mol. Neurodegener. 2016;11:76. doi: 10.1186/s13024-016-0141-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13024-016-0141-0</ArticleId><ArticleId IdType="pmc">PMC5148922</ArticleId><ArticleId IdType="pubmed">27938392</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang W., Wei W., Gaertig M.A., Li S., Li X.-J. Therapeutic Effect of Berberine on Huntington&#x2019;s Disease Transgenic Mouse Model. PLoS ONE. 2015;10:e0134142. doi: 10.1371/journal.pone.0134142.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0134142</ArticleId><ArticleId IdType="pmc">PMC4520448</ArticleId><ArticleId IdType="pubmed">26225560</ArticleId></ArticleIdList></Reference><Reference><Citation>Mealer R.G., Murray A.J., Shahani N., Subramaniam S., Snyder S.H. Rhes, a striatal-selective protein implicated in Huntington disease, binds beclin-1 and activates autophagy. J. Biol. Chem. 2014;289:3547&#x2013;3554. doi: 10.1074/jbc.M113.536912.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M113.536912</ArticleId><ArticleId IdType="pmc">PMC3916556</ArticleId><ArticleId IdType="pubmed">24324270</ArticleId></ArticleIdList></Reference><Reference><Citation>Perucho J., G&#xf3;mez A., Mu&#xf1;oz M.P., de Y&#xe9;benes J.G., Mena M.&#xc1;., Casarejos M.J. Trehalose rescues glial cell dysfunction in striatal cultures from HD R6/1 mice at early postnatal development. Mol. Cell Neurosci. 2016;74:128&#x2013;145. doi: 10.1016/j.mcn.2016.05.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mcn.2016.05.002</ArticleId><ArticleId IdType="pubmed">27236019</ArticleId></ArticleIdList></Reference><Reference><Citation>Fox L., Yamamoto A. Examining aggregates through the eyes of WDFY3/Alfy. Autophagy. 2020;16:967&#x2013;968. doi: 10.1080/15548627.2020.1739448.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/15548627.2020.1739448</ArticleId><ArticleId IdType="pmc">PMC7144867</ArticleId><ArticleId IdType="pubmed">32150493</ArticleId></ArticleIdList></Reference><Reference><Citation>Fox L.M., Kim K., Johnson C.W., Chen S., Croce K.R., Victor M.B., Eenjes E., Bosco J.R., Randolph L.K., Dragatsis I., et al. Huntington&#x2019;s Disease Pathogenesis Is Modified In Vivo by Alfy/Wdfy3 and Selective Macroautophagy. Neuron. 2020;105:813&#x2013;821.e6. doi: 10.1016/j.neuron.2019.12.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2019.12.003</ArticleId><ArticleId IdType="pmc">PMC7060123</ArticleId><ArticleId IdType="pubmed">31899071</ArticleId></ArticleIdList></Reference><Reference><Citation>Isakson P., Holland P., Simonsen A. The role of ALFY in selective autophagy. Cell Death Differ. 2013;20:12&#x2013;20. doi: 10.1038/cdd.2012.66.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/cdd.2012.66</ArticleId><ArticleId IdType="pmc">PMC3524637</ArticleId><ArticleId IdType="pubmed">22653340</ArticleId></ArticleIdList></Reference><Reference><Citation>Sarkar S., Perlstein E.O., Imarisio S., Pineau S., Cordenier A., Maglathlin R.L., Webster J.A., Lewis T.A., O&#x2019;Kane C.J., Schreiber S.L., et al. Small molecules enhance autophagy and reduce toxicity in Huntington&#x2019;s disease models. Nat. Chem. Biol. 2007;3:331&#x2013;338. doi: 10.1038/nchembio883.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nchembio883</ArticleId><ArticleId IdType="pmc">PMC2635561</ArticleId><ArticleId IdType="pubmed">17486044</ArticleId></ArticleIdList></Reference><Reference><Citation>Song F., Xie K. Calcium-dependent neutral cysteine protease and organophosphate-induced delayed neuropathy. Chem. Biol. Interact. 2012;200:114&#x2013;118. doi: 10.1016/j.cbi.2012.10.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cbi.2012.10.001</ArticleId><ArticleId IdType="pubmed">23092810</ArticleId></ArticleIdList></Reference><Reference><Citation>Damodaran T.V., Attia M.K., Abou-Donia M.B. Early differential cell death and survival mechanisms initiate and contribute to the development of OPIDN, a study of molecular, cellular, and anatomical parameters. Toxicol. Appl. Pharmacol. 2011;256:348&#x2013;359. doi: 10.1016/j.taap.2011.07.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.taap.2011.07.017</ArticleId><ArticleId IdType="pubmed">21840330</ArticleId></ArticleIdList></Reference><Reference><Citation>Emerick G.L., DeOliveira G.H., dos Santos A.C., Ehrich M. Mechanisms for consideration for intervention in the development of organophosphorus-induced delayed neuropathy. Chem. Biol. Interact. 2012;199:177&#x2013;184. doi: 10.1016/j.cbi.2012.07.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cbi.2012.07.002</ArticleId><ArticleId IdType="pubmed">22819951</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu H.-Y., Wang P., Sun Y.-J., Xu M.-Y., Zhu L., Wu Y.-J. Activation of Neuregulin 1/ErbB Signaling Is Involved in the Development of TOCP-Induced Delayed Neuropathy. Front. Mol. Neurosci. 2018;11:129. doi: 10.3389/fnmol.2018.00129.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnmol.2018.00129</ArticleId><ArticleId IdType="pmc">PMC5925568</ArticleId><ArticleId IdType="pubmed">29740279</ArticleId></ArticleIdList></Reference><Reference><Citation>Long D.-X., Hu D., Wang P., Wu Y.-J. Induction of autophagy in human neuroblastoma SH-SY5Y cells by tri-ortho-cresyl phosphate. Mol. Cell Biochem. 2014;396:33&#x2013;40. doi: 10.1007/s11010-014-2139-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11010-014-2139-7</ArticleId><ArticleId IdType="pubmed">24990248</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen J.-X., Sun Y.-J., Wang P., Long D.-X., Li W., Li L., Wu Y.-J. Induction of autophagy by TOCP in differentiated human neuroblastoma cells lead to degradation of cytoskeletal components and inhibition of neurite outgrowth. Toxicology. 2013;310:92&#x2013;97. doi: 10.1016/j.tox.2013.05.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tox.2013.05.012</ArticleId><ArticleId IdType="pubmed">23743148</ArticleId></ArticleIdList></Reference><Reference><Citation>Pandya R.S., Mao L.L.J., Zhou E.W., Bowser R., Zhu Z., Zhu Y., Wang X. Neuroprotection for amyotrophic lateral sclerosis, role of stem cells, growth factors, and gene therapy. Cent. Nerv. Syst. Agents Med. Chem. 2012;12:15&#x2013;27.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4170803</ArticleId><ArticleId IdType="pubmed">22283698</ArticleId></ArticleIdList></Reference><Reference><Citation>Pandya R.S., Zhu H., Li W., Bowser R., Friedlander R.M., Wang X. Therapeutic neuroprotective agents for amyotrophic lateral sclerosis. Cell Mol. Life Sci. 2013;70:4729&#x2013;4745. doi: 10.1007/s00018-013-1415-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00018-013-1415-0</ArticleId><ArticleId IdType="pmc">PMC4172456</ArticleId><ArticleId IdType="pubmed">23864030</ArticleId></ArticleIdList></Reference><Reference><Citation>Suzuki N., Nishiyama A., Kato M., Warita H., Aoki M. Familial Amyotrophic Lateral Sclerosis. Brain Nerve. 2019;71:1169&#x2013;1181.</Citation><ArticleIdList><ArticleId IdType="pubmed">31722303</ArticleId></ArticleIdList></Reference><Reference><Citation>Cristofani R., Crippa V., Rusmini P., Cicardi M.E., Meroni M., Nausicaa V., Giorgetti E., Grunseich C., Galbiati M., Piccolella M., et al. Inhibition of retrograde transport modulates misfolded protein accumulation and clearance in motoneuron diseases. Autophagy. 2017;13:1280&#x2013;1303. doi: 10.1080/15548627.2017.1308985.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/15548627.2017.1308985</ArticleId><ArticleId IdType="pmc">PMC5584856</ArticleId><ArticleId IdType="pubmed">28402699</ArticleId></ArticleIdList></Reference><Reference><Citation>Bowerman M., Murray L.M., Scamps F., Schneider B.L., Kothary R., Raoul C. Pathogenic commonalities between spinal muscular atrophy and amyotrophic lateral sclerosis, Converging roads to therapeutic development. Eur. J. Med. Genet. 2018;61:685&#x2013;698. doi: 10.1016/j.ejmg.2017.12.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejmg.2017.12.001</ArticleId><ArticleId IdType="pubmed">29313812</ArticleId></ArticleIdList></Reference><Reference><Citation>Baradaran-Heravi Y., Van Broeckhoven C., van der Zee J. Stress granule mediated protein aggregation and underlying gene defects in the FTD-ALS spectrum. Neurobiol. Dis. 2020;134:104639. doi: 10.1016/j.nbd.2019.104639.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2019.104639</ArticleId><ArticleId IdType="pubmed">31626953</ArticleId></ArticleIdList></Reference><Reference><Citation>Madill M., McDonagh K., Ma J., Vajda A., McLoughlin P., O&#x2019;Brien T., Hardiman O., Shen S. Amyotrophic lateral sclerosis patient iPSC-derived astrocytes impair autophagy via non-cell autonomous mechanisms. Mol. Brain. 2017;10:22. doi: 10.1186/s13041-017-0300-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13041-017-0300-4</ArticleId><ArticleId IdType="pmc">PMC5470320</ArticleId><ArticleId IdType="pubmed">28610619</ArticleId></ArticleIdList></Reference><Reference><Citation>Mori F., Miki Y., Kon T., Tanji K., Wakabayashi K. Autophagy Is a Common Degradation Pathway for Bunina Bodies and TDP-43 Inclusions in Amyotrophic Lateral Sclerosis. J. Neuropathol. Exp. Neurol. 2019;78:910&#x2013;921. doi: 10.1093/jnen/nlz072.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jnen/nlz072</ArticleId><ArticleId IdType="pubmed">31504678</ArticleId></ArticleIdList></Reference><Reference><Citation>Kochergin I.A., Shpilyukova Y.A., Lysogorskaia E.V., Abramycheva N.Y., Zakharova M.N., Illarioshkin S.N. Effect of Mutations in SOD1 and C9orf72 Genes on Autophagy in Lymphomonocytes in Myotrophic Lateral Sclerosis. Bull. Exp. Biol. Med. 2019;167:667&#x2013;670. doi: 10.1007/s10517-019-04595-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10517-019-04595-w</ArticleId><ArticleId IdType="pubmed">31625064</ArticleId></ArticleIdList></Reference><Reference><Citation>Dobson-Stone C., Hallupp M., Shahheydari H., Ragagnin A.M.G., Chatterton Z., Carew-Jones F., Shepherd C.E., Stefen H., Paric E., Fath T., et al. CYLD is a causative gene for frontotemporal dementia&#x2014;Amyotrophic lateral sclerosis. Brain. 2020;143:783&#x2013;799. doi: 10.1093/brain/awaa039.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awaa039</ArticleId><ArticleId IdType="pmc">PMC7089666</ArticleId><ArticleId IdType="pubmed">32185393</ArticleId></ArticleIdList></Reference><Reference><Citation>Toth R.P., Atkin J.D. Dysfunction of Optineurin in Amyotrophic Lateral Sclerosis and Glaucoma. Front. Immunol. 2018;9:1017. doi: 10.3389/fimmu.2018.01017.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2018.01017</ArticleId><ArticleId IdType="pmc">PMC5974248</ArticleId><ArticleId IdType="pubmed">29875767</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Y., Liu H., Guan Y., Wang Q., Zhou F., Jie L., Ju J., Pu L., Du H., Wang X. The altered autophagy mediated by TFEB in animal and cell models of amyotrophic lateral sclerosis. Am. J. Transl. Res. 2015;7:1574&#x2013;1587.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4626419</ArticleId><ArticleId IdType="pubmed">26550457</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu J., Zhang L., Yang Y., Guo Y., Fan Y., Zhang M., Man W., Gao E., Hu W., Reiter R.J., et al. Melatonin alleviates postinfarction cardiac remodeling and dysfunction by inhibiting MstJ. Pineal Res. 2017;62:e12368. doi: 10.1111/jpi.12368.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jpi.12368</ArticleId><ArticleId IdType="pubmed">27696525</ArticleId></ArticleIdList></Reference><Reference><Citation>Jauhari A., Baranov S.V., Suofu Y., Kim J., Singh T., Yablonska S., Li F., Wang X., Oberly P., Minnigh M.B., et al. Melatonin inhibits cytosolic mitochondrial-DNA induced neuroinflammatory signaling in accelerated aging and neurodegeneration. J. Clin. Investig. 2020;130:3124&#x2013;3136. doi: 10.1172/JCI135026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI135026</ArticleId><ArticleId IdType="pmc">PMC7260019</ArticleId><ArticleId IdType="pubmed">32182222</ArticleId></ArticleIdList></Reference><Reference><Citation>Tordjman S., Chokron S., Delorme R., Charrier A., Bellissant E., Jaafari N., Fougerou C. Melatonin, Pharmacology, Functions and Therapeutic Benefits. Curr. Neuropharmacol. 2017;15:434&#x2013;443. doi: 10.2174/1570159X14666161228122115.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1570159X14666161228122115</ArticleId><ArticleId IdType="pmc">PMC5405617</ArticleId><ArticleId IdType="pubmed">28503116</ArticleId></ArticleIdList></Reference><Reference><Citation>Magri F., Sarra S., Cinchetti W., Guazzoni V., Fioravanti M., Cravello L., Ferrari E. Qualitative and quantitative changes of melatonin levels in physiological and pathological aging and in centenarians. J. Pineal Res. 2004;36:256&#x2013;261. doi: 10.1111/j.1600-079X.2004.00125.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1600-079X.2004.00125.x</ArticleId><ArticleId IdType="pubmed">15066050</ArticleId></ArticleIdList></Reference><Reference><Citation>Schernhammer E., Chen H., Ritz B. Circulating melatonin levels, possible link between Parkinson&#x2019;s disease and cancer risk? Cancer Causes Control. 2006;17:577&#x2013;582. doi: 10.1007/s10552-005-9002-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10552-005-9002-9</ArticleId><ArticleId IdType="pubmed">16596313</ArticleId></ArticleIdList></Reference><Reference><Citation>Skene D.J. Optimization of light and melatonin to phase-shift human circadian rhythms. J. Neuroendocrinol. 2003;15:438&#x2013;441. doi: 10.1046/j.1365-2826.2003.01006.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1365-2826.2003.01006.x</ArticleId><ArticleId IdType="pubmed">12622847</ArticleId></ArticleIdList></Reference><Reference><Citation>Wongprayoon P., Govitrapong P. Melatonin as a mitochondrial protector in neurodegenerative diseases. Cell Mol. Life Sci. 2017;74:3999&#x2013;4014. doi: 10.1007/s00018-017-2614-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00018-017-2614-x</ArticleId><ArticleId IdType="pubmed">28791420</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang L.-F., Zhou Z.-W., Wang Z.-H., Du Y.-H., He Z.-X., Cao C., Zhou S.-F. Coffee and caffeine potentiate the antiamyloidogenic activity of melatonin via inhibition of A&#x3b2; oligomerization and modulation of the Tau-mediated pathway in N2a/APP cells. Drug Des. Devel. Ther. 2015;9:241&#x2013;272.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4284031</ArticleId><ArticleId IdType="pubmed">25565776</ArticleId></ArticleIdList></Reference><Reference><Citation>Stefanova N.A., Maksimova K.Y., Kiseleva E., Rudnitskaya E.A., Muraleva N.A., Kolosova N.G. Melatonin attenuates impairments of structural hippocampal neuroplasticity in OXYS rats during active progression of Alzheimer&#x2019;s disease-like pathology. J. Pineal Res. 2015;59:163&#x2013;177. doi: 10.1111/jpi.12248.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jpi.12248</ArticleId><ArticleId IdType="pubmed">25988948</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee J., Giordano S., Zhang J. Autophagy, mitochondria and oxidative stress, cross-talk and redox signalling. Biochem. J. 2012;441:523&#x2013;540. doi: 10.1042/BJ20111451.</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/BJ20111451</ArticleId><ArticleId IdType="pmc">PMC3258656</ArticleId><ArticleId IdType="pubmed">22187934</ArticleId></ArticleIdList></Reference><Reference><Citation>Gelmetti V., De Rosa P., Torosantucci L., Marini E.S., Romagnoli A., Di Rienzo M., Arena G., Vignone D., Fimia G.M., Valente E.M. PINK1 and BECN1 relocalize at mitochondria-associated membranes during mitophagy and promote ER-mitochondria tethering and autophagosome formation. Autophagy. 2017;13:654&#x2013;669. doi: 10.1080/15548627.2016.1277309.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/15548627.2016.1277309</ArticleId><ArticleId IdType="pmc">PMC5388214</ArticleId><ArticleId IdType="pubmed">28368777</ArticleId></ArticleIdList></Reference><Reference><Citation>Hamasaki M., Furuta N., Matsuda A., Nezu A., Yamamoto A., Fujita N., Oomori H., Noda T., Haraguchi T., Hiraoka Y., et al. Autophagosomes form at ER-mitochondria contact sites. Nature. 2013;495:389&#x2013;393. doi: 10.1038/nature11910.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature11910</ArticleId><ArticleId IdType="pubmed">23455425</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez A., Ord&#xf3;&#xf1;ez R., Reiter R.J., Gonz&#xe1;lez-Gallego J., Mauriz J.L. Melatonin and endoplasmic reticulum stress, relation to autophagy and apoptosis. J. Pineal Res. 2015;59:292&#x2013;307. doi: 10.1111/jpi.12264.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jpi.12264</ArticleId><ArticleId IdType="pubmed">26201382</ArticleId></ArticleIdList></Reference><Reference><Citation>Scheper W., Nijholt D.A., Hoozemans J.J. The unfolded protein response and proteostasis in Alzheimer disease, preferential activation of autophagy by endoplasmic reticulum stress. Autophagy. 2011;7:910&#x2013;911. doi: 10.4161/auto.7.8.15761.</Citation><ArticleIdList><ArticleId IdType="doi">10.4161/auto.7.8.15761</ArticleId><ArticleId IdType="pmc">PMC3149694</ArticleId><ArticleId IdType="pubmed">21494086</ArticleId></ArticleIdList></Reference><Reference><Citation>Polito V.A., Li H., Martini-Stoica H., Wang B., Yang L., Xu Y., Swartzlander D.B., Palmieri M., di Ronza A., Lee V.M., et al. Selective clearance of aberrant tau proteins and rescue of neurotoxicity by transcription factor EB. EMBO Mol. Med. 2014;6:1142&#x2013;1160. doi: 10.15252/emmm.201303671.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/emmm.201303671</ArticleId><ArticleId IdType="pmc">PMC4197862</ArticleId><ArticleId IdType="pubmed">25069841</ArticleId></ArticleIdList></Reference><Reference><Citation>Dragicevic N., Copes N., O&#x2019;Neal-Moffitt G., Jin J., Buzzeo R., Mamcarz M., Tan J., Cao C., Olcese J.M., Arendash G.W., et al. Melatonin treatment restores mitochondrial function in Alzheimer&#x2019;s mice, a mitochondrial protective role of melatonin membrane receptor signaling. J. Pineal Res. 2011;51:75&#x2013;86. doi: 10.1111/j.1600-079X.2011.00864.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1600-079X.2011.00864.x</ArticleId><ArticleId IdType="pubmed">21355879</ArticleId></ArticleIdList></Reference><Reference><Citation>Garc&#xed;a S., Mart&#xed;n Gim&#xe9;nez V.M., Mocayar Mar&#xf3;n F.J., Reiter R.J., Manucha W. Melatonin and cannabinoids, mitochondrial-targeted molecules that may reduce inflammaging in neurodegenerative diseases. Histol. Histopathol. 2020;35:789&#x2013;800.</Citation><ArticleIdList><ArticleId IdType="pubmed">32154907</ArticleId></ArticleIdList></Reference><Reference><Citation>Srivastava A.K., Roy Choudhury S., Karmakar S. Melatonin/polydopamine nanostructures for collective neuroprotection-based Parkinson&#x2019;s disease therapy. Biomat. Sci. 2020;8:1345&#x2013;1363. doi: 10.1039/C9BM01602C.</Citation><ArticleIdList><ArticleId IdType="doi">10.1039/C9BM01602C</ArticleId><ArticleId IdType="pubmed">31912833</ArticleId></ArticleIdList></Reference><Reference><Citation>Fasciani I., Petragnano F., Aloisi G., Marampon F., Rossi M., Coppolino M.F., Rossi R., Longoni B., Scarselli M., Maggio R. A New Threat to Dopamine Neurons, The Downside of Artificial Light. Neuroscience. 2020;432:216&#x2013;228. doi: 10.1016/j.neuroscience.2020.02.047.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroscience.2020.02.047</ArticleId><ArticleId IdType="pubmed">32142863</ArticleId></ArticleIdList></Reference><Reference><Citation>Tamura H., Jozaki M., Tanabe M., Shirafuta Y., Mihara Y., Shinagawa M., Tamura I., Maekawa R., Sato S., Taketani T., et al. Importance of Melatonin in Assisted Reproductive Technology and Ovarian Aging. Int. J. Mol. Sci. 2020;21:1135. doi: 10.3390/ijms21031135.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms21031135</ArticleId><ArticleId IdType="pmc">PMC7036809</ArticleId><ArticleId IdType="pubmed">32046301</ArticleId></ArticleIdList></Reference><Reference><Citation>Su L.-Y., Li H., Lv L., Feng Y.-M., Li G.-D., Luo R., Zhou H.-J., Lei X.-G., Ma L., Li J.-L., et al. Melatonin attenuates MPTP-induced neurotoxicity via preventing CDK5-mediated autophagy and SNCA/&#x3b1;-synuclein aggregation. Autophagy. 2015;11:1745&#x2013;1759. doi: 10.1080/15548627.2015.1082020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/15548627.2015.1082020</ArticleId><ArticleId IdType="pmc">PMC4824603</ArticleId><ArticleId IdType="pubmed">26292069</ArticleId></ArticleIdList></Reference><Reference><Citation>Cadet J.L., Krasnova I.N. Molecular bases of methamphetamine-induced neurodegeneration. Int. Rev. Neurobiol. 2009;88:101&#x2013;119.</Citation><ArticleIdList><ArticleId IdType="pubmed">19897076</ArticleId></ArticleIdList></Reference><Reference><Citation>Park J., Seo J., Won J., Yeo H.-G., Ahn Y.-J., Kim K., Jin Y.B., Koo B.-S., Lim K.S., Jeong K.-J., et al. Abnormal Mitochondria in a Non-human Primate Model of MPTP-induced Parkinson&#x2019;s Disease, Drp1 and CDK5/p25 Signaling. Exp. Neurobiol. 2019;28:414&#x2013;424. doi: 10.5607/en.2019.28.3.414.</Citation><ArticleIdList><ArticleId IdType="doi">10.5607/en.2019.28.3.414</ArticleId><ArticleId IdType="pmc">PMC6614070</ArticleId><ArticleId IdType="pubmed">31308800</ArticleId></ArticleIdList></Reference><Reference><Citation>Togashi K., Hasegawa M., Nagai J., Tonouchi A., Masukawa D., Hensley K., Goshima Y., Ohshima T. Genetic suppression of collapsin response mediator protein 2 phosphorylation improves outcome in methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinson&#x2019;s model mice. Genes Cells. 2019;24:31&#x2013;40. doi: 10.1111/gtc.12651.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/gtc.12651</ArticleId><ArticleId IdType="pubmed">30375127</ArticleId></ArticleIdList></Reference><Reference><Citation>He F., Qi G., Zhang Q., Cai H., Li T., Li M., Zhang Q., Chen J., Ming J., Tian B., et al. Quantitative Phosphoproteomic Analysis in Alpha-Synuclein Transgenic Mice Reveals the Involvement of Aberrant p25/Cdk5 Signaling in Early-stage Parkinson&#x2019;s Disease. Cell Mol. Neurobiol. 2020;40:897&#x2013;909. doi: 10.1007/s10571-019-00780-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10571-019-00780-7</ArticleId><ArticleId IdType="pubmed">32016637</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun Y., Sukumaran P., Selvaraj S., Cilz N.I., Schaar A., Lei S., Singh B.B. TRPM2 Promotes Neurotoxin MPP+/MPTP-Induced Cell Death. Mol. Neurobiol. 2018;55:409&#x2013;420. doi: 10.1007/s12035-016-0338-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-016-0338-9</ArticleId><ArticleId IdType="pmc">PMC5468501</ArticleId><ArticleId IdType="pubmed">27957685</ArticleId></ArticleIdList></Reference><Reference><Citation>Mack J.M., Schamne M.G., Sampaio T.B., P&#xe9;rtile R.A.N., Fernandes P.A.C.M., Markus R.P., Prediger R.D. Melatoninergic System in Parkinson&#x2019;s Disease, From Neuroprotection to the Management of Motor and Nonmotor Symptoms. Oxid. Med. Cell Longev. 2016;2016:3472032. doi: 10.1155/2016/3472032.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2016/3472032</ArticleId><ArticleId IdType="pmc">PMC5088323</ArticleId><ArticleId IdType="pubmed">27829983</ArticleId></ArticleIdList></Reference><Reference><Citation>Tapias V., Cannon J.R., Greenamyre J.T. Melatonin treatment potentiates neurodegeneration in a rat rotenone Parkinson&#x2019;s disease model. J. Neurosci. Res. 2010;88:420&#x2013;427. doi: 10.1002/jnr.22201.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jnr.22201</ArticleId><ArticleId IdType="pubmed">19681169</ArticleId></ArticleIdList></Reference><Reference><Citation>Singhal N.K., Srivastava G., Agrawal S., Jain S.K., Singh M.P. Melatonin as a neuroprotective agent in the rodent models of Parkinson&#x2019;s disease, is it all set to irrefutable clinical translation? Mol. Neurobiol. 2012;45:186&#x2013;199. doi: 10.1007/s12035-011-8225-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-011-8225-x</ArticleId><ArticleId IdType="pubmed">22198804</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu J., Liu W., Lu Y., Tian H., Duan C., Lu L., Gao G., Wu X., Wang X., Yang H. Piperlongumine restores the balance of autophagy and apoptosis by increasing BCL2 phosphorylation in rotenone-induced Parkinson disease models. Autophagy. 2018;14:845&#x2013;861. doi: 10.1080/15548627.2017.1390636.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/15548627.2017.1390636</ArticleId><ArticleId IdType="pmc">PMC6070010</ArticleId><ArticleId IdType="pubmed">29433359</ArticleId></ArticleIdList></Reference><Reference><Citation>Han X., Sun S., Sun Y., Song Q., Zhu J., Song N., Chen M., Sun T., Xia M., Ding J., et al. Small molecule-driven NLRP3 inflammation inhibition via interplay between ubiquitination and autophagy, implications for Parkinson disease. Autophagy. 2019;15:1860&#x2013;1881. doi: 10.1080/15548627.2019.1596481.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/15548627.2019.1596481</ArticleId><ArticleId IdType="pmc">PMC6844502</ArticleId><ArticleId IdType="pubmed">30966861</ArticleId></ArticleIdList></Reference><Reference><Citation>Nopparat C., Porter J.E., Ebadi M., Govitrapong P. The mechanism for the neuroprotective effect of melatonin against methamphetamine-induced autophagy. J. Pineal Res. 2010;49:382&#x2013;389. doi: 10.1111/j.1600-079X.2010.00805.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1600-079X.2010.00805.x</ArticleId><ArticleId IdType="pubmed">20738755</ArticleId></ArticleIdList></Reference><Reference><Citation>Schwarcz R., Coyle J.T. Striatal lesions with kainic acid, neurochemical characteristics. Brain Res. 1977;127:235&#x2013;249. doi: 10.1016/0006-8993(77)90538-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0006-8993(77)90538-8</ArticleId><ArticleId IdType="pubmed">16686</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang C.-F., Huang H.-J., Lee H.-C., Hung K.-C., Wu R.-T., Lin A.M.-Y. Melatonin attenuates kainic acid-induced neurotoxicity in mouse hippocampus via inhibition of autophagy and &#x3b1;-synuclein aggregation. J. Pineal Res. 2012;52:312&#x2013;321. doi: 10.1111/j.1600-079X.2011.00945.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1600-079X.2011.00945.x</ArticleId><ArticleId IdType="pubmed">22212051</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou H., Chen J., Lu X., Shen C., Zeng J., Chen L., Pei Z. Melatonin protects against rotenone-induced cell injury via inhibition of Omi and Bax-mediated autophagy in Hela cells. J. Pineal Res. 2012;52:120&#x2013;127. doi: 10.1111/j.1600-079X.2011.00926.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1600-079X.2011.00926.x</ArticleId><ArticleId IdType="pubmed">21883444</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim B.J., Ryu S.W., Song B.J. JNK- and p38 kinase-mediated phosphorylation of Bax leads to its activation and mitochondrial translocation and to apoptosis of human hepatoma HepG2 cells. J. Biol. Chem. 2006;281:21256&#x2013;21265. doi: 10.1074/jbc.M510644200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M510644200</ArticleId><ArticleId IdType="pubmed">16709574</ArticleId></ArticleIdList></Reference><Reference><Citation>Jenwitheesuk A., Nopparat C., Mukda S., Wongchitrat P., Govitrapong P. Melatonin regulates aging and neurodegeneration through energy metabolism, epigenetics, autophagy and circadian rhythm pathways. Int. J. Mol. Sci. 2014;15:16848&#x2013;16884. doi: 10.3390/ijms150916848.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms150916848</ArticleId><ArticleId IdType="pmc">PMC4200827</ArticleId><ArticleId IdType="pubmed">25247581</ArticleId></ArticleIdList></Reference><Reference><Citation>Mammucari C., Rizzuto R. Signaling pathways in mitochondrial dysfunction and aging. Mech. Ageing Dev. 2010;131:536&#x2013;543. doi: 10.1016/j.mad.2010.07.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mad.2010.07.003</ArticleId><ArticleId IdType="pmc">PMC2948971</ArticleId><ArticleId IdType="pubmed">20655326</ArticleId></ArticleIdList></Reference><Reference><Citation>Reynolds-Peterson C., Xu J., Zhao N., Cruse C., Yonel B., Trasorras C., Toyoda H., Kinoshita-Toyoda A., Dobson J., Schultheis N., et al. Heparan Sulfate Structure Affects Autophagy, Lifespan, Responses to Oxidative Stress, and Cell Degeneration in Drosophila parkin Mutants. G3 Genes Genomes Genet. 2020;10:129&#x2013;141. doi: 10.1534/g3.119.400730.</Citation><ArticleIdList><ArticleId IdType="doi">10.1534/g3.119.400730</ArticleId><ArticleId IdType="pmc">PMC6945019</ArticleId><ArticleId IdType="pubmed">31672849</ArticleId></ArticleIdList></Reference><Reference><Citation>Eldeeb M.A., Ragheb M.A. N-degron-mediated degradation and regulation of mitochondrial PINK1 kinase. Curr. Genet. 2020;66:693&#x2013;701. doi: 10.1007/s00294-020-01062-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00294-020-01062-2</ArticleId><ArticleId IdType="pubmed">32157382</ArticleId></ArticleIdList></Reference><Reference><Citation>Tanaka K. The PINK1-Parkin Axis, an Overview. Neurosci. Res. 2020 doi: 10.1016/j.neures.2020.01.006. in press.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neures.2020.01.006</ArticleId><ArticleId IdType="pubmed">31982458</ArticleId></ArticleIdList></Reference><Reference><Citation>Ikeda F., Dikic I. Atypical ubiquitin chains, new molecular signals. Protein Modifications: Beyond the Usual Suspects&#x2019; Review Series. EMBO Rep. 2008;9:536&#x2013;542. doi: 10.1038/embor.2008.93.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/embor.2008.93</ArticleId><ArticleId IdType="pmc">PMC2427391</ArticleId><ArticleId IdType="pubmed">18516089</ArticleId></ArticleIdList></Reference><Reference><Citation>Scherz-Shouval R., Elazar Z. Regulation of autophagy by ROS, physiology and pathology. Trends Biochem. Sci. 2011;36:30&#x2013;38. doi: 10.1016/j.tibs.2010.07.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tibs.2010.07.007</ArticleId><ArticleId IdType="pubmed">20728362</ArticleId></ArticleIdList></Reference><Reference><Citation>Kongsuphol P., Mukda S., Nopparat C., Villarroel A., Govitrapong P. Melatonin attenuates methamphetamine-induced deactivation of the mammalian target of rapamycin signaling to induce autophagy in SK-N-SH cells. J. Pineal Res. 2009;46:199&#x2013;206. doi: 10.1111/j.1600-079X.2008.00648.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1600-079X.2008.00648.x</ArticleId><ArticleId IdType="pubmed">19054297</ArticleId></ArticleIdList></Reference><Reference><Citation>Frost B., Diamond M.I. Prion-like mechanisms in neurodegenerative diseases. Nat. Rev. Neurosci. 2010;11:155&#x2013;159. doi: 10.1038/nrn2786.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrn2786</ArticleId><ArticleId IdType="pmc">PMC3648341</ArticleId><ArticleId IdType="pubmed">20029438</ArticleId></ArticleIdList></Reference><Reference><Citation>Jeong J.-K., Moon M.-H., Lee Y.-J., Seol J.-W., Park S.-Y. Melatonin-induced autophagy protects against human prion protein-mediated neurotoxicity. J. Pineal Res. 2012;53:138&#x2013;146. doi: 10.1111/j.1600-079X.2012.00980.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1600-079X.2012.00980.x</ArticleId><ArticleId IdType="pubmed">22335252</ArticleId></ArticleIdList></Reference><Reference><Citation>Jeong J.-K., Park S.-Y. Melatonin regulates the autophagic flux via activation of alpha-7 nicotinic acetylcholine receptors. J. Pineal Res. 2015;59:24&#x2013;37. doi: 10.1111/jpi.12235.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jpi.12235</ArticleId><ArticleId IdType="pubmed">25808024</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y., Cook A., Kim J., Baranov S.V., Jiang J., Smith K., Cormier K., Bennett E., Browser R.P., Day A.L., et al. Melatonin inhibits the caspase-1/cytochrome c/caspase-3 cell death pathway, inhibits MT1 receptor loss and delays disease progression in a mouse model of amyotrophic lateral sclerosis. Neurobiol. Dis. 2013;55:26&#x2013;35. doi: 10.1016/j.nbd.2013.03.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2013.03.008</ArticleId><ArticleId IdType="pmc">PMC3652329</ArticleId><ArticleId IdType="pubmed">23537713</ArticleId></ArticleIdList></Reference><Reference><Citation>Weishaupt J.H., Bartels C., P&#xf6;lking E., Dietrich J., Rohde G., Poeggeler B., Mertens N., Sperling S., Bohn M., H&#xfc;ther G., et al. Reduced oxidative damage in ALS by high-dose enteral melatonin treatment. J. Pineal Res. 2006;41:313&#x2013;323. doi: 10.1111/j.1600-079X.2006.00377.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1600-079X.2006.00377.x</ArticleId><ArticleId IdType="pubmed">17014688</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang X. The Antiapoptotic Activity of Melatonin in Neurodegenerative Diseases. CNS Neurosci. Ther. 2009;15:345&#x2013;357. doi: 10.1111/j.1755-5949.2009.00105.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1755-5949.2009.00105.x</ArticleId><ArticleId IdType="pmc">PMC2846661</ArticleId><ArticleId IdType="pubmed">19818070</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang X., Sirianni A., Pei Z., Cormier K., Smith K., Jiang J., Zhou S., Wang H., Zhao R., Yano H., et al. The Melatonin MT1 Receptor Axis Modulates Mutant Huntingtin-Mediated Toxicity. J. Neurosci. 2011;31:14496&#x2013;14507. doi: 10.1523/JNEUROSCI.3059-11.2011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.3059-11.2011</ArticleId><ArticleId IdType="pmc">PMC3213696</ArticleId><ArticleId IdType="pubmed">21994366</ArticleId></ArticleIdList></Reference><Reference><Citation>Rademakers R., Sleegers K., Theuns J., Van den Broeck M., Bel Kacem S., Nilsson L.-G., Adolfsson R., van Duijn C.M., Van Broeckhoven C., Cruts M. Association of cyclin-dependent kinase 5 and neuronal activators p35 and p39 complex in early-onset Alzheimer&#x2019;s disease. Neurobiol. Aging. 2005;26:1145&#x2013;1151. doi: 10.1016/j.neurobiolaging.2004.10.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2004.10.003</ArticleId><ArticleId IdType="pubmed">15917097</ArticleId></ArticleIdList></Reference><Reference><Citation>Gutierrez-Cuesta J., Sureda F.X., Romeu M., Canudas A.M., Caballero B., Coto-Montes A., Camins A., Pall&#xe0;s M. Chronic administration of melatonin reduces cerebral injury biomarkers in SAMPJ. Pineal Res. 2007;42:394&#x2013;402. doi: 10.1111/j.1600-079X.2007.00433.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1600-079X.2007.00433.x</ArticleId><ArticleId IdType="pubmed">17439556</ArticleId></ArticleIdList></Reference><Reference><Citation>Alvira D., Tajes M., Verdaguer E., Acu&#xf1;a-Castroviejo D., Folch J., Camins A., Pallas M. Inhibition of the cdk5/p25 fragment formation may explain the antiapoptotic effects of melatonin in an experimental model of Parkinson&#x2019;s disease. J. Pineal Res. 2006;40:251&#x2013;258. doi: 10.1111/j.1600-079X.2005.00308.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1600-079X.2005.00308.x</ArticleId><ArticleId IdType="pubmed">16499562</ArticleId></ArticleIdList></Reference><Reference><Citation>Luchetti F., Canonico B., Curci R., Battistelli M., Mannello F., Papa S., Tarzia G., Falcieri E. Melatonin prevents apoptosis induced by UV-B treatment in U937 cell line. J. Pineal Res. 2006;40:158&#x2013;167. doi: 10.1111/j.1600-079X.2005.00293.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1600-079X.2005.00293.x</ArticleId><ArticleId IdType="pubmed">16441553</ArticleId></ArticleIdList></Reference><Reference><Citation>Fischer T.W., Zbytek B., Sayre R.M., Apostolov E.O., Basnakian A.G., Sweatman T.W., Wortsman J., Elsner P., Slominski A. Melatonin increases survival of HaCaT keratinocytes by suppressing UV-induced apoptosis. J. Pineal Res. 2006;40:18&#x2013;26. doi: 10.1111/j.1600-079X.2005.00273.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1600-079X.2005.00273.x</ArticleId><ArticleId IdType="pubmed">16313494</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehrzadi S., Hemati K., Reiter R.J., Hosseinzadeh A. Mitochondrial dysfunction in age-related macular degeneration, melatonin as a potential treatment. Exp. Opin. Ther. Targets. 2020;24:359&#x2013;378. doi: 10.1080/14728222.2020.1737015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/14728222.2020.1737015</ArticleId><ArticleId IdType="pubmed">32116056</ArticleId></ArticleIdList></Reference><Reference><Citation>Reiter R., Tan D., Rosales-Corral S., Galano A., Zhou X., Xu B. Mitochondria, Central Organelles for Melatonin&#x2032;s Antioxidant and Anti-Aging Actions. Molecules. 2018;23:509.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6017324</ArticleId><ArticleId IdType="pubmed">29495303</ArticleId></ArticleIdList></Reference><Reference><Citation>Leon J., Acu&#xf1;a-Castroviejo D., Sainz R.M., Mayo J.C., Tan D.-X., Reiter R.J. Melatonin and mitochondrial function. Life Sci. 2004;75:765&#x2013;790. doi: 10.1016/j.lfs.2004.03.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lfs.2004.03.003</ArticleId><ArticleId IdType="pubmed">15183071</ArticleId></ArticleIdList></Reference><Reference><Citation>Thomas B., Mohanakumar K.P. Melatonin protects against oxidative stress caused by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in the mouse nigrostriatum. J. Pineal Res. 2004;36:25&#x2013;32. doi: 10.1046/j.1600-079X.2003.00096.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1600-079X.2003.00096.x</ArticleId><ArticleId IdType="pubmed">14675127</ArticleId></ArticleIdList></Reference><Reference><Citation>Maharaj D.S., Maharaj H., Daya S., Glass B.D. Melatonin and 6-hydroxymelatonin protect against iron-induced neurotoxicity. J. Neurochem. 2006;96:78&#x2013;81. doi: 10.1111/j.1471-4159.2005.03532.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1471-4159.2005.03532.x</ArticleId><ArticleId IdType="pubmed">16300638</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang X., Figueroa B.E., Stavrovskaya I.G., Zhang Y., Sirianni A.C., Zhu S., Day A.L., Kristal B.S., Friedlander R.M. Methazolamide and melatonin inhibit mitochondrial cytochrome C release and are neuroprotective in experimental models of ischemic injury. Stroke. 2009;40:1877&#x2013;1885.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2674528</ArticleId><ArticleId IdType="pubmed">19299628</ArticleId></ArticleIdList></Reference><Reference><Citation>Vishnoi S., Raisuddin S., Parvez S. Glutamate Excitotoxicity and Oxidative Stress in Epilepsy, Modulatory Role of Melatonin. J. Environ. Pathol. Toxicol. Oncol. 2016;35:365&#x2013;374. doi: 10.1615/JEnvironPatholToxicolOncol.2016016399.</Citation><ArticleIdList><ArticleId IdType="doi">10.1615/JEnvironPatholToxicolOncol.2016016399</ArticleId><ArticleId IdType="pubmed">27992316</ArticleId></ArticleIdList></Reference><Reference><Citation>Beker M.C., Caglayan A.B., Kelestemur T., Caglayan B., Yalcin E., Yulug B., Kilic U., Hermann D.M., Kilic E. Effects of normobaric oxygen and melatonin on reperfusion injury, role of cerebral microcirculation. Oncotarget. 2015;6:30604&#x2013;30614. doi: 10.18632/oncotarget.5773.</Citation><ArticleIdList><ArticleId IdType="doi">10.18632/oncotarget.5773</ArticleId><ArticleId IdType="pmc">PMC4741555</ArticleId><ArticleId IdType="pubmed">26416428</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee S.-H., Chun W., Kong P.-J., Han J.A., Cho B.P., Kwon O.-Y., Lee H.J., Kim S.-S. Sustained activation of Akt by melatonin contributes to the protection against kainic acid-induced neuronal death in hippocampus. J. Pineal Res. 2006;40:79&#x2013;85. doi: 10.1111/j.1600-079X.2005.00283.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1600-079X.2005.00283.x</ArticleId><ArticleId IdType="pubmed">16313502</ArticleId></ArticleIdList></Reference><Reference><Citation>Beker M.C., Caglayan B., Caglayan A.B., Kelestemur T., Yalcin E., Caglayan A., Kilic U., Baykal A.T., Reiter R.J., Kilic E. Interaction of melatonin and Bmal1 in the regulation of PI3K/AKT pathway components and cellular survival. Sci. Rep. 2019;9:19082.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6910929</ArticleId><ArticleId IdType="pubmed">31836786</ArticleId></ArticleIdList></Reference><Reference><Citation>Armstrong K.J., Niles L.P. Induction of GDNF mRNA expression by melatonin in rat C6 glioma cells. Neuroreport. 2002;13:473&#x2013;475. doi: 10.1097/00001756-200203250-00023.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00001756-200203250-00023</ArticleId><ArticleId IdType="pubmed">11930164</ArticleId></ArticleIdList></Reference><Reference><Citation>Phillipson O.T. Alpha-synuclein, epigenetics, mitochondria, metabolism, calcium traffic &amp; circadian dysfunction in Parkinson&#x2019;s disease. An integrated strategy for management. Ageing Res. Rev. 2017;40:149&#x2013;167.</Citation><ArticleIdList><ArticleId IdType="pubmed">28986235</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharma R., McMillan C.R., Tenn C.C., Niles L.P. Physiological neuroprotection by melatonin in a 6-hydroxydopamine model of Parkinson&#x2019;s disease. Brain Res. 2006;1068:230&#x2013;236. doi: 10.1016/j.brainres.2005.10.084.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainres.2005.10.084</ArticleId><ArticleId IdType="pubmed">16375867</ArticleId></ArticleIdList></Reference><Reference><Citation>Olcese J.M., Cao C., Mori T., Mamcarz M.B., Maxwell A., Runfeldt M.J., Wang L., Zhang C., Lin X., Zhang G., et al. Protection against cognitive deficits and markers of neurodegeneration by long-term oral administration of melatonin in a transgenic model of Alzheimer disease. J. Pineal Res. 2009;47:82&#x2013;96. doi: 10.1111/j.1600-079X.2009.00692.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1600-079X.2009.00692.x</ArticleId><ArticleId IdType="pubmed">19538338</ArticleId></ArticleIdList></Reference><Reference><Citation>Khatoon R., Rasheed M.Z., Rawat M., Alam M.M., Tabassum H., Parvez S. Effect of melatonin on A&#x3b2;42 induced changes in the mitochondrial function related to Alzheimer&#x2019;s disease in Drosophila melanogaster. Neurosci. Lett. 2019;711:134376. doi: 10.1016/j.neulet.2019.134376.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neulet.2019.134376</ArticleId><ArticleId IdType="pubmed">31325578</ArticleId></ArticleIdList></Reference><Reference><Citation>Hossain M.F., Uddin M.S., Uddin G.M.S., Sumsuzzman D.M., Islam M.S., Barreto G.E., Mathew B., Ashraf G.M. Melatonin in Alzheimer&#x2019;s Disease, A Latent Endogenous Regulator of Neurogenesis to Mitigate Alzheimer&#x2019;s Neuropathology. Mol. Neurobiol. 2019;56:8255&#x2013;8276. doi: 10.1007/s12035-019-01660-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-019-01660-3</ArticleId><ArticleId IdType="pubmed">31209782</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu J., Gao H., Zhang L., Rong S., Yang W., Ma C., Chen M., Huang Q., Deng Q., Huang F. Melatonin alleviates cognition impairment by antagonizing brain insulin resistance in aged rats fed a high-fat diet. J. Pineal Res. 2019;67:e12584. doi: 10.1111/jpi.12584.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jpi.12584</ArticleId><ArticleId IdType="pubmed">31050371</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang Z., Bao Y., Chen W., He Y. Melatonin exerts neuroprotective effects by attenuating astro- and microgliosis and suppressing inflammatory response following spinal cord injury. Neuropeptides. 2020;79:102002. doi: 10.1016/j.npep.2019.102002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.npep.2019.102002</ArticleId><ArticleId IdType="pubmed">31902595</ArticleId></ArticleIdList></Reference><Reference><Citation>Permpoonputtana K., Tangweerasing P., Mukda S., Boontem P., Nopparat C., Govitrapong P. Long-term administration of melatonin attenuates neuroinflammation in the aged mouse brain. EXCLI J. 2018;17:634&#x2013;646.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6088215</ArticleId><ArticleId IdType="pubmed">30108467</ArticleId></ArticleIdList></Reference><Reference><Citation>Hardeland R. Melatonin and inflammation-Story of a double-edged blade. J. Pineal Res. 2018;65:e12525. doi: 10.1111/jpi.12525.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jpi.12525</ArticleId><ArticleId IdType="pubmed">30242884</ArticleId></ArticleIdList></Reference><Reference><Citation>Luo C., Yang Q., Liu Y., Zhou S., Jiang J., Reiter R.J., Bhattacharya P., Cui Y., Yang H., Ma H., et al. The multiple protective roles and molecular mechanisms of melatonin and its precursor N-acetylserotonin in targeting brain injury and liver damage and in maintaining bone health. Free Radic. Biol. Med. 2019;130:215&#x2013;233. doi: 10.1016/j.freeradbiomed.2018.10.402.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.freeradbiomed.2018.10.402</ArticleId><ArticleId IdType="pubmed">30315933</ArticleId></ArticleIdList></Reference><Reference><Citation>Ram&#xed;rez-Rodr&#xed;guez G.B., Olvera-Hern&#xe1;ndez S., Vega-Rivera N.M., Ortiz-L&#xf3;pez L. Melatonin Influences Structural Plasticity in the Axons of Granule Cells in the Dentate Gyrus of Balb/C Mice. Int. J. Mol. Sci. 2018;20:73. doi: 10.3390/ijms20010073.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms20010073</ArticleId><ArticleId IdType="pmc">PMC6337618</ArticleId><ArticleId IdType="pubmed">30585191</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Neal-Moffitt G., Pilli J., Kumar S.S., Olcese J. Genetic deletion of MT1/MT2 melatonin receptors enhances murine cognitive and motor performance. Neuroscience. 2014;277:506&#x2013;521. doi: 10.1016/j.neuroscience.2014.07.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroscience.2014.07.018</ArticleId><ArticleId IdType="pubmed">25046530</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>